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Radiation oncology is the field of medicine that deals with treating cancer pa-
tients through ionizing radiation. The clinical modality or technique used to treat the
cancer patients in the radiation oncology domain is referred to as radiation therapy.
Radiation therapy aims to deliver precisely measured dose irradiation to a defined
tumor volume (target) with as minimal damage as possible to surrounding healthy
tissue (organs-at-risk), resulting in eradication of the tumor, high quality of life, and
prolongation of survival. A typical radiotherapy process requires the use of different
clinical systems at various stages of the workflow. The data generated in these differ-
ent stages of workflow is stored in an unstructured and non-standard format, which
hinders interoperability and interconnectivity of data, thereby making it difficult to
translate all of these datasets into knowledge that supports decision-making in routine
clinical practice. In this dissertation, we present an enterprise-level informatics plat-
form that can automatically extract and efficiently store clinical, treatment, imaging,
xv
and genomics data from radiation oncology patients. Additionally, we propose data
science methods for data standardization, safety, and treatment quality analysis in ra-
diation oncology. We demonstrate that our data standardization methods using word
embeddings and machine learning are robust and highly generalizable on real-word
clinical datasets collected from the nationwide radiation therapy centers administered
by the US Veterans’ Health Administration. We also present different heterogeneous
data integration approaches to enhance the data standardization process. For patient
safety, we analyze the radiation oncology incident reports and propose an integrated
natural language processing and machine learning based pipeline to automate the in-
cident triage and prioritization process. We demonstrate that a deep learning based
transfer learning approach helps in the automated incident triage process. Finally, we
address the issue of treatment quality in terms of automated treatment planning in
clinical decision support systems. We show that supervised machine learning methods
can efficiently generate clinical hypotheses from radiation oncology treatment plans




In the domain of radiation oncology, large amounts of data are captured routinely
across several clinical systems over the course of patients’ treatment. The electronic
health record (EHR) systems are used to document clinical data, which are often
stored in free text and unstructured format, wherein key data fields become difficult
to abstract for any subsequent data mining efforts. For each patient treated by the
radiation oncology department, clinical documentation in the EHR includes the fol-
lowing: (1) a detailed initial consultation note; (2) a simulation note describing the
treatment simulation procedure; (3) a treatment planning note documenting the pre-
scription and proposed treatment plan; (4) a weekly On Treatment Visit (OTV) note
from the staff physician review of patient’s treatment progress and documenting acute
side effects; (5) a treatment summary or survivorship care plan for the patient and
referring provider at completion of therapy; and (6) routine follow-up notes tracking
disease outcomes and any late toxicities. These clinical notes are usually dictated on
the telephone, transcribed and imported into the EHR as preliminary documents, and
edited by the dictation provider before finalization. There is a wealth of information
in these clinical notes for big data applications but the challenge is to capture this
data in a discrete format as part of the standard clinical workflow.
The dosimetry data from the treatment planning systems (TPS) which includes
the treatment plan, images, dose, structure set, and dose-volume information are
stored in structured formats by following the DICOM-RT standard and TG-263
nomenclature [1]. Additionally, the radiotherapy treatment management system
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(RTMS) contains information regarding the Radiotherapy (RT) dose delivery, frac-
tions, visits. Each of these clinical systems store data for different purposes, in dif-
ferent formats and in different databases and also employ different mechanisms for
sharing these data. For example, the radiation oncologist must access the two software
systems mentioned above to clinically manage patients. Moreover, most RT product
vendors have no incentive in accommodating each other’s data or translate their data
format into a standardized nomenclature. The lack of inter-connectivity and inter-
operability of RT software systems have made the process of data sharing and/or
transfer cumbersome and difficult. Hence, valuable clinical and radiation treatment
data unfortunately remain trapped behind such proprietary software systems.
The second challenge is that if RT data are manually aggregated and stored
in one database, it becomes extremely difficult to clean, parse, collate and scale the
data intelligibly. This prevents the ability to create a coherent picture of the patient’s
comprehensive clinical and treatment record into a single format capable of further
utilities and data analytics. This is largely because physician’s clinical assessments
and diagnoses are often stored as free-text notes, making it extremely difficult to
extract critical information with enough accuracy on an automated level. Owing to
such challenges, many research and operational tasks that deal with the optimization
of quality of care, research-based analysis of RT treatments, diagnosis-based research
and development of computer-aided diagnostic tools at infrastructural level are dif-
ficult to perform. To this end, the National Radiation Oncology Program (NROP)
office at the US Veterans’ Health Administration (VHA) designed an initiative to de-
velop an integrated enterprise-wide data curation, storage and analytics portal, called
HINGE (Health Information Gateway and Exchange). HINGE is electronically con-
nected to the EHR, TMS and TPS with a specific goal of enabling big data analytics
in radiation oncology. It is an automatic data aggregator that collates data from dif-
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ferent radiotherapy clinical systems/IT applications. It processes the treatment data
for quality assessment, predictive analytics and other enterprise-driven clinical infor-
matics solutions within a single online data portal. Additionally, HINGE’s design and
infrastructure caters to the imminent need for a research-based practice environment
and is cognizant of the role of advanced modern computational strategies involving
big-data predictive analytics and clinical informatics.
In this dissertation, we present an agile and scalable software architecture of
the HINGE system and different data science approaches to solve the issues related
to data standardization, patient safety, and treatment quality assurance in radiation
oncology.
In Chapter 2, we present the details of the different clinical systems that were used
in data collection along with a workflow of the radiation therapy treatment process
to motivate a high-level software architecture for the enterprise-level HINGE system.
We also present an outline of the data science methods and relevant evaluation metrics
that were employed in this dissertation.
In Chapter 3 and 4, we present the different approaches to standardize the ra-
diotherapy structure names. Specific contributions of Chapter 3 are as follows.
1. We present a machine learning approach to standardize the radiotherapy struc-
ture names that can automatically convert the arbitrary physician-given struc-
ture names to the domain wide TG-263 based nomenclature.
2. We demonstrate that a relatively small amount of data from each treatment
center is enough to build a generalizable machine learning model, which a simple
text mapping cannot achieve.
3. We establish that our proposed approach is disease site agnostic, i.e., it can be
used on multiple disease sites.
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4. We also demonstrate that physician-given names hold enough information about
the structures that can be utilized to predict the standard names in TG-263.
5. Finally, we create a scalable approach that requires little to no preprocessing.
In Chapter 4, we address the limitations of structure name standardization using
solely physician-given names and present an approach that utilizes the geometric
information of structures for standardization. Specific contributions of this chapter
are as follows.
1. We demonstrate that the use of bony anatomy information along with structures
helps in the standardization process using geometric information.
2. We show that even target structure can be identified along with the Organs at
Risk (OARs) with the physician-given names.
3. We demonstrate that it is still challenging to predict the standard name with
just geometric information in real-world clinical datasets.
4. We finally demonstrate that integrating physician-given structure names with
geometric information of structures improves the overall structure name stan-
dardization process.
In Chapter 5, we focus on the safety aspects of radiation oncology. We specifically
looked at the triage process in incident learning system. In this chapter, we present
machine learning approaches to automatically identify incident severity with an over-
arching goal of automating the incident triage and prioritization process. Specific
contribution of this chapter are as follows.
1. We present an approach to automatically identify the severity of the radiation
oncology incidents using the textual incident description.
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2. We demonstrate that identifying the severity is a challenging problem when it
comes to classifying the incidents into the four possible categories using just the
incident description. However, merging severity types into two categories (High
and Low severities) results in much better classification accuracy considering
the incident report data from multiple VHA radiation oncology centers as well
as the VCU medical center datasets.
3. We next demonstrate that transfer learning does help in the severity prediction
process specifically considering multi-institution data that may each follow a
different protocol for recording the incident reports.
4. We show that incident reports are correlated with institutional practices and
there is a need for standardized incident reporting guidelines to reduce the
subjective incident analysis practices.
Finally, in Chapter 6, we consider the treatment quality component of the radi-
ation therapy process.
1. We present feature engineering methods to analyze the treatment selection prac-
tices for High or Intermediate risk prostate cancer patients across 34 different
VHA radiation therapy centers.
2. We demonstrate that there is an inherent bias in the treatment selection process
at the VHA treatment centers. The selected treatments deviate from the NCCN
guidelines and there is little to no correlation for this deviation with specific
treatment center attributes such as, number of radiation oncologists, radiation
therapists, other staff or treatment resources.
Figure 1 shows the dissertation outline. Chapters 3 and 4 use material from four
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different publications [2, 3, 4, 5]. Chapter 5, uses material from [6, 7]. Chapter 6 uses
the material from [8, 9].
Fig 1: Thesis contribution flow chart. Contributions are done in three domains in




2.1 Radiation Therapy Process
It is imperative to understand the layout and structure of RT clinical workflow
while building solutions for the issues involved. The RT clinical workflow can be
divided into four steps. Figure 2 shows the RT clinical workflow. The steps involved
in the RT workflow are mentioned below.
• Consultation: In this step, patients meet with a radiation oncologist and they
both go through the available treatment options. The radiation oncologist asks
a series of questions to determine the best possible treatment options.
• Treatment Planning: The radiation oncologist scans the patients using CT
or MRI and simulates the radiation treatment to determine the best course
of treatment. Simulation involves the identification of the target (tumor) and
neighboring anatomical structures to ensure minimal radiation exposure to the
healthy tissues.
• Treatment Delivery: In this step, the actual treatment is delivered. It in-
volves keeping a record of the treatment delivered and scanning to enable mod-
ifications to the treatment according to the patient’s response to the treatment.
• Follow-up: Once the treatment is complete, radiation oncologists set up a
series of follow up meetings with the patients to keep track of the disease. It also
helps the patients in providing details on their quality of life, post-treatment,
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and receive appropriate care to improve it.
Fig 2: Typical radiotherapy clinical workflow. Four major steps in RT process are
shown and type of data generated in each step is shown on the right.
Each patient encounter or a set of encounters is documented in different clinical
systems within the department as the patient progresses through the sequential ra-
diotherapy (RT) workflow. Figure 3 shows the clinical workflow and the respective
clinical system used in each step of the RT process.
Electronic Health Records (EHRs) are a digital version of a patient’s paper chart.
EHRs are real-time, patient-centered records that make information available in-
stantly and securely to authorized users. On the other hand, treatment planning
systems (TPS) contain information about a prescribed radiation therapy treatment
plan by physicians and dosimetrists. Treatment management systems (TMS) use
plans generated by the TPS as input and deliver the radiation to the patient. These
individual systems often comprise of proprietary software that records and documents
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Fig 3: Encounters between physicians and patients during the entire treatment. The
information is recorded in different clinical IT systems: EHR, TPS and TMS.
this information. Besides these clinical systems, most of the radiation oncology de-
partments make use of incident learning systems (ILS). This system is used to report
incidents that occur at all stages of the RT workflow. A major quality enhancement
criteria for the ILS system is to be able to automatically classify incident reports into
different severity categories as addressed in this dissertation. This is needed to opti-
mize the operations and resources allocated to attend to incidents of varying severity
and improve the overall quality of care.
These independent clinical systems have their own interfaces, proprietary data
format and databases which are not interoperable with each other. Data from all
these systems need to be extracted which in itself is a giant institutional task since
it involves integrating research-based modules (i.e., algorithms, machine learning and
natural language processing) with clinical systems (i.e., data). Such a transition from
concepts to applications needs a new layered software infrastructure, as shown in
Figure 4 [2].
Treatment data of patients has to be routinely accessed from the clinical tier,
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Fig 4: Overview of an informatics-driven clinical infrastructure. Data exchange hap-
pens across several tiers which are modularized for specific services.
parsed through the aggregation tier and made available through data sharing in-
terfaces to act as endpoints for the research-based algorithms/applications. In ad-
dition to the data acquisition challenges, other important parameters such as, per-
missions/rights regarding the surrounding architecture, data type, data structures,
data rules/restrictions, privacy and compliance, institutional review board (IRB)
approvals, data security, etc. have to be resolved too. Building an informatics-
driven clinical infrastructure embedded with artificial intelligence (AL) and/or ma-
chine learning (ML) tools, requires investment and participation from all the stake-
holders and policy makers of the clinical institution.
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Fig 5: Radiation oncology data curation, standardization, and analytics platform
(EMR, TPS, TMS, and RO-ILS).
2.2 Naming Standards
The present lack of radiotherapy structure name standardization in practice not
be associated with the actual inexistence of standards. Multiple standards have been
proposed, and the widespread attention of the clinical world to the need for naming
standards is increasing [10]. In this section, we discuss the one such standard used in
RT medical practices.
Ontologies
Ontologies provide a rich framework for defining concepts and inter-relationships
among them. The BioPortal [11] is a website that is maintained by the National
Center for Biomedical Ontology contains a wide variety of medical ontologies that
are publicly accessible. Ontologies are helpful to represent essential components in
interoperability and integration into healthcare informatics.
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American Association of Physicists in Medicine’s Task Group-263
The American Association of Physicists in Medicine (AAPM) is a scientific and
professional organization. One of the primary goals of AAPM is to identify and
implement improvements in patient safety for the medical use of radiation in imaging
and radiation therapy.
In 2018, AAPM released the final report of its task group numbered 263 (TG-
263) [12], with a focus on identifying a comprehensive nomenclature standard for RT,
which could be efficiently and proficiently used in every medical institution in the
United States. Task group developed a comprehensive nomenclature system of all
the concepts after reviewing the already available medical ontologies and the recent
development in standards for nomenclature in RT [13, 14]. Special consideration was
given to practical limitations (like characters supported by vendors’ solutions) and
the utilization of names to minimize the chance of communication errors. Essential
RT concepts that were not covered in other medical ontologies are covered in detail.
TG-263 is not an ontology but can be considered as a set of simple naming guidelines
and conventions. As a result, TG-263 names are short but easy to understand and
interpret, even without a strong anatomy background. When possible, it provides
the most closely matching Foundational Model of Anatomy (FMA) identifier of the
structure, thus providing the direct linking between the FMA and TG-263. An ac-
curately standardized TG-263 clinical dataset is more useful for medical purposes.
Also, it will make it easier to use semantic web technologies, thanks to the integra-
tion with the FMA ontology. The standard structure names continuously updated
and made publicly accessible [1]. With the easy to follow guidelines and tremendous
adoption of medical practices, a new challenge has emerged in the radiation oncology
domain, updating retrospective DICOM datasets with standardized structure names
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compliant with the TG-263 standard.
2.3 Machine Learning Algorithms
Here, we will briefly describe the supervised machine learning algorithms that
have been used in this dissertation.
In a supervised machine learning approach, algorithms know the correct labels
of the data it is trying to learn. We have used supervised classification algorithms
that try to learn a patterns to categorize the data points into two or more categories.
Below are some of the classification algorithms used in this dissertation.
Logistic Regression (LR)
Logistic regression is a simple linear classification algorithm that takes in a vector
and converts it to the probability ranging between 0 and 1. It uses a sigmoid function
to convert the value. For binary classification, a cutoff value is used to decide the class
label. It is easy to interpret due to its linear nature. Even though it is predominantly
used for binary classification, it can also be used for multi-class classification.
Support Vector Machines (SVM)
Support vector machines make use of a hyperplane or a set of hyperplanes to
distinctively classify the data points. Linear SVM makes use of maximum-margin
hyperplanes to classify the linearly separable datapoints [15]. Alternatively, non-linear
SVM uses the function to map the input vector to a high-dimensional or infinite-
dimensional vector space and determines the hyperplane in the new space to classify
the data points [16]. It has been previously observed that SVMs have consistently
outperformed many other classifiers in text categorization problems, and they are less
susceptible to imbalanced datasets [17].
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k-Nearest Neighbors (kNN)
(kNN) [18] is a simple but powerful machine learning algorithm that can be used
for both supervised and unsupervised learning. This algorithm finds the k -nearest
neighbors in a dataset (with n samples) when compared to a new example. The
distances between examples are calculated on each feature with a distance metric
such as Euclidean, Manhattan, or Mahalanobis. The only parameter for kNN is the
value k itself. According to [19], choosing k to be
√
n is a good option, although other
values may be better depending on the properties of the dataset and application.
Unlike many machine learning algorithms, the traditional kNN algorithm does
not require a training phase as the queries are simply compared against the examples
in the existing dataset. Although the brute force kNN will produce the true k -nearest
neighbors, it will also have poor computational performance as the number of example
queries or the underlying dataset becomes large.
Random Forests (RF)
Random Forests consists of multiple decision trees, but each tree can only be
split based on the randomly selected subset of features from the randomly selected
samples. For each tree, different subset of samples and subset of features are selected
randomly. For classification, majority voted label is considered as the predicted label
[20].
2.4 Machine Learning Model Training Process
Training a machine learning model involves a lot of experimentation, such as
selecting different algorithms and selecting appropriate hyperparameters. The final
selected model needs to be optimized by choosing a different set of hyperparameters.
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Each set of hyperparameters with training data leads to a different model. Since
we are interested in selecting the best performing model from this set, we need to
compare their performance. The dataset is divided into the following three sets to
train and select the best machine learning model.
• Training Set: This contains the instances and labels used for training the
model.
• Validation Set: This is used to calculate the performance of the model and
hyper-parameter selection.
• Testing Set: This set is used to test the predictive performance of the final
selected model. Test set samples are never seen by the model either at training
or validation, thus mimicking the real-world data.
To correctly estimate the model performance, we assume that training, vali-
dation, and test sets are coming from the same distribution. In classification, to
maintain a similar distribution across each set, data is split in such a way that an
equal percentage of instances from each class are in each set, which is also known as
a stratified split.
2.5 Evaluation Metrics
The performance of a model is evaluated by comparing the model’s prediction
against the actual (true) class. In classification, a confusion matrix is used to describe
the model’s predictions.
Figure 6 shows the confusion matrix for a binary classification task. In binary
classification, data points are divided into two classes; Positive (P) and Negative (N)




Fig 6: A diagrammatic representation of binary classification confusion matrix.
True Positive (TP): This is when the model predicted a positive class and the
actual class is also positive.
False Positive (FP): The model predicted a positive, but the actual class is
negative.
False Negative (FN): This is when the model predicted a negative, but the
actual class is positive.
True Negative (TN): The model predicted a negative and the actual class is
also negative.
Using the confusion matrix components, different types of classification metrics
















TP + TN + FP + FN
(2.4)
For multi-class classification, an overall model’s performance can be calculated
using these metrics. A macro-averaged metric computes results for each class inde-
pendently and then takes the average of all the classes to calculate the overall average
metric. In contrast, a micro-average aggregates the contributions of all classes to com-
pute the overall metric. We note that in classification tasks such as ours, in which
each structure name is mapped to precisely one label (as in the structure name stan-
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dardization problem), accuracy is the same as the micro-averaged F1-Score. A micro-
averaged F1-Score and overall accuracy metric do not disproportionately penalize a
classifier for performing poorly on the less frequent classes, whereas macro-averaged
F1-Score is heavily influenced by how well the classifier performs on the less frequent
classes. Hence the performance of a rare class and a more frequent class are equally
important.
Accuracy measures how well a classifier performs overall, whereas macro-averaged
precision, recall, and F1-Scores better capture how well a classifier can identify cases
that it does not often see, which is extremely important in real-world settings.
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CHAPTER 3
RADIOTHERAPY STRUCTURE NAME STANDARDIZATION
USING PHYSICIAN-GIVEN NAMES
Fig 7: Thesis contribution, Chapter 3 contributions are highlighted.
3.1 Introduction
Radiation therapy is a type of cancer treatment that uses high intensity energy
beams to kill cancer cells and shrink the tumor. In order to treat cancer, the radiation
oncologist delineates the tumorous region or target volume on a computed tomogra-
phy (CT) or magnetic resonance imaging (MRI) dataset. Additionally, the normal
organs, known as organs-at-risk (OAR) volumes are delineated to spare and estimate
radiation doses and reduce possible side effects. These delineated volumes are known
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as structures. Radiation oncology team members, such as radiation physicists and
dosimetrists, delineate other types of structures termed as “planning organs at risk
volume” (PRV). These structures are used strictly in the treatment planning process
and take into account the mobility of the organs at risk, and therefore, a surrounding
margin is added to these structures to compensate for geometric uncertainties. All
delineated structures are given names that are usually written in free text as identi-
fiers, but the lack of standardized nomenclature has created inconsistencies in naming
the structures. Figure 8 shows a representative CT image overlaid with its defined
structures. The left side of the figure shows the physician-transcribed names of the
structures delineated on the right side.
The use of standard nomenclature is an essential step for the construction and
use of informatics-based tools to automatically extract pertinent data from electronic
medical records in support of clinical trials, data-pooling initiatives, and clinical prac-
tice improvement. It also provides a foundation for the development of software tools
to automate data extraction, analysis, data submission, exchange, and quality assur-
ance (QA) [21, 22].
To address these issues, the American Association of Physicists in Medicine
(AAPM) has released a Task Group 263 (TG-263) report with the standardized
nomenclature for structures names [12]. This report was developed in collabora-
tion with stakeholders from both multi-institutional and multi-vendor organizations.
The American Society for Radiation Oncology (ASTRO) and AAPM have identified
the following as the main challenges in RT structure name standardization [12]:
• Vendor-based challenges that originate from the inter-vendor variation on soft-
ware architecture. Each vendor has a particular character set for naming the
structures; limited allowable character sets, however, hinder the interoperability.
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Fig 8: A representative CT image overlaid with its defined structures. The left side
of the figure shows the physician-transcribed names of the structures delineated on
the right side. The physician-transcribed names and structures delineated can be
matched by the color.
• Multi-institutional-based challenges that may arise from the lack of participa-
tion, oversight, and guidelines in creating a standardized nomenclature.
• Single institutional challenges include data governance issues, costs, and dif-
ficulties in implementing new nomenclatures, making them compatible with
existing treatment modalities, and training the institutional staff to follow the
standards.
• Clinical staff challenges may encompass the lack of guidelines or a detailed
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schema to follow.
Strict adherence to a standardized nomenclature will help to achieve future stan-
dardization, but it cannot address retrospective data standardization. Manually rela-
beling inconsistent names with the corresponding standardized TG-263 names is one
way to correct retrospective data; however, generating such mappings for multi-center
data is slow, time consuming, inefficient, hard to generalize, and challenging to scale.
This sets the stage for machine learning (ML) based methods that may be able to
overcome some of these limitations. To address each of the issues mentioned above,
we propose a methodology to retrospectively standardize the radiotherapy structure
names using a combination of ML and natural language processing (NLP) techniques.
The main contributions of this chapter are:
• Proposing a novel automated machine learning approach to standardize the
physician-given structure names to the domain wide utilized TG-263 standard
names.
• Demonstrating that a relatively small amount of data from each center is enough
to build a generalizable machine learning model, which a simple text mapping
cannot achieve.
• Establishing that the approach is disease site agnostic; it can be used on multiple
disease sites.
• Demonstrating that physician-given names hold enough information about the
structures that can be utilized to predict the standard name.
• Creating a scalable approach that requires little to no preprocessing.
3.2 Related Work
The existing techniques for structure name standardization can be broadly classi-
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fied into three categories: expert-based, ontology-based, and machine learning based.
Previous works in the RT community to retrospectively standardize structure
names mostly use the physician provided names (free-text labels) or geometric infor-
mation such as volume, area, and location of the structures. The recently published
works to standardize structure names using physician-given names are illustrated as
below.
A research team in Australia recently proposed an expert-based approach to stan-
dardize radiotherapy structure names as per the TG-263 standard recommendations
[23]. In this study, a panel of experts developed a mapping and structure synonym
set for 36 structures from their clinical database. With their method, they were able
to map 99% of the relevant structures and relabel the names correctly. However,
the major limitation of this approach are scalability and generalizability; data used
in this project were from a single academically focused institution that could enforce
the local standards, and the mappings were dependent on inputs provided by experts.
This method is also center specific; mappings from one institute may not be useful
to the other institute.
A different team in the Netherlands has proposed an ontology-based RESTful
web service to standardize the structure names [24]. However, this approach was more
focused on building a linked data than a technique for structure name standardization.
The authors used the mappings provided by the institutions to generate centralized
mappings, thereby creating a common terminology for linked data.
There are few works that have proposed machine learning based approaches to
structure name standardization. Unlike expert-based and ontology-based methods,
machine learning based methods use either free text labels or geometric information to
build learning models for standardization. One such work made use of multiple string
similarity measures to generate feature vectors, and these feature vectors were used
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as input for the classification algorithm to predict the labels [25]. This paper used
neural-network-based methods but lacked the pertinent details for reproducibility of
the results. Two other papers proposed methods using geometrical information for
structure name standardization [26, 27]. Both of these papers have used a machine
learning approach with neural networks to standardize the structure names of the
head and neck region. Even though they both showed a high accuracy for identifying
the standard names, the major limitation of these works was that they considered
only limited OAR structures to build the ML model and Non OARs were discarded.
Removing Non OAR structures makes it difficult to apply these two approaches in
the real-world datasets which contain a mixture of both OARs and Non OARs.
Expert-based methods have high accuracy but require manual effort from expe-
rienced clinicians, which makes scalability and generalizability challenging to achieve.
Although ontology-based techniques can help in automating the labeling task, there
is a paucity of domain-specific comprehensive ontologies in the radiation oncology
domain. Machine learning based methods are well suited for retrospective struc-
ture name relabeling but are seldom used in this domain. Additionally, the TG-263
standardization was only completed in 2018 [12], and hence applications of machine
learning based methods for structure name prediction are still in their infancy.
3.3 Methods and Materials
3.3.1 Annotation Process
As part of VA-ROQS, teams of domain experts visited each of the 40 VA facilities
that performed radiotherapy in-house and extracted patient data from the local EMR
and TPS. The original treatment planning data was reloaded in the TPS software, and
the associated imaging, dose and structure set information was reviewed. Using the
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full treatment planning information, the domain experts then built a data table that
mapped original structure set labels to the preferred TG-263 labels. The structure
label standardization was originally performed so that dose-related Quality Measures
could be compared across all VA facilities; the resulting information was also used as
the true labels for the predictive models in our pipeline. The same annotation process
was performed on the VCU data with a local expert.
3.3.2 Dataset
Across the United States, the Veterans Health Administration (VA) has 40 cen-
ters treating veterans with in-house radiation therapy services. The VA has put
together the Radiation Oncology Quality Surveillance Program (VA-ROQS), and as
part of this program the treatment quality is assessed from all VA centers [28]. As
part of the initial pilot study, data from all 40 centers were manually abstracted from
clinical charts, imaging databases, and radiation oncology specific systems, such as
treatment planning systems and treatment management systems. Data from up to
20 prostate and 20 lung cancer patients were manually abstracted from each center,
resulting in a total of 794 and 754 patients respectively. The collected data included
the DICOM (Digital Imaging and Communication in Medicine) structure set files
representing anatomical structures of interest and the corresponding DICOM CT im-
age datasets for each patient. For this project, ten lung and nine prostate OAR
structures were identified. These structures were manually labeled to their TG-263
standard names, and all other structures, including target and PRVs, were labeled as
Non OAR. The dataset will be further referred to as the VA-ROQS dataset.
We also collected data from the Department of Radiation Oncology at Virginia
Commonwealth University (VCU) as an external test dataset, which included DI-
COM structure set data from 50 randomly selected patients with prostate cancer
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and another 50 patients with lung cancer. The same procedure that was used in the
VA-ROQS data preparation was also used to label the structures in this dataset with
a local expert, which will be referred to as the VCU dataset.
The structure label standardization was originally performed so that dose related
Quality Measures could be compared across all VA facilities; the resulting information
was also used as the true labels for the predictive models in our pipeline. Assigning
standard labels to DICOM structures was a very time consuming process and has
motivated us to find a more automated or semi-automated solution for structure
label standardization. This automated solution can additionally help in reducing
possible human errors in the manual annotation process.
The following prostate and lung OAR structures were considered in this work:
Prostate organs-at-risk structures: Bladder, Rectum, LargeBowel, SmallBowel,
Femur L, Femur R, SeminalVesicles, PenileBulb, and External.
Lung organs-at-risk structures: Heart, Esophagus, Lungs, Lung R, Lung L, Spin-
calCord, BrachialPlexus, BrachialPlexus L, BrachialPlexus R, and External.
Table 1 shows the distributions of lung structures for the VA-ROQS and VCU
datasets, while Table 2 shows the distributions of the prostate structures in these two
datasets. In both cases, the Non OAR structures present an overwhelming majority;
these Non OARs include all the structures contoured as a part of treatment planning
and delivery and the dose evaluation structures. We also observed similar class im-
balances across all VA-ROQS centers’ data (see Figures 40 and 41 in Appendix B).
Table 3 shows the examples of physician-given names compared to the standard OAR
structures, which highlights the variability in the physician-given names. Table 1 also
shows the number of unique names found in each Lung structure in the VA-ROQS
and VCU datasets, and Table 2 shows physician-given unique names for the prostate
structures in VA-ROQS and VCU datasets.
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VA-ROQS VCU
Non Standard Name Non Standard Name
Standard Name Total Count Unique Count Total Count Unique Count
Brachial Plexus 44 11 0 0
Brachial Plexus L 59 14 4 5
Brachial Plexus R 69 23 5 3
Carina 497 7 33 2
Esophagus 636 28 46 4
Heart 693 21 47 2
Lung L 553 46 28 10
Lung R 563 46 27 10
Lungs 439 39 41 10
Non OAR 8800 3701 577 259
SpinalCord 689 37 50 7
Total 13,044 3973 858 309
Table 1: Lung structure type distribution in VA-ROQS and VCU datasets.
3.3.3 Data Preprocessing
Structure names are short and have a limited character set to use, and the
available character set is vendor dependent. As shown in Table 3, even though there
is high variability in physician-given structure names for most of the structure types,
the character set used is limited. Preprocessing methods need to be selected to ensure
that critical information is retained; losing the information might negatively affect
the ability to standardize the structure names with high fidelity. Hence, we decided
to keep the preprocessing of physician-given names to a minimum by just converting
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VA-ROQS VCU
Non Standard Name Non Standard Name
Standard Name Total Count Unique Count Total Count Unique Count
SmallBowel 250 40 47 7
LargeBowel 341 33 6 2
Femur R 717 62 31 14
Femur L 711 59 32 16
Rectum 742 14 50 3
Bladder 738 10 50 3
External 597 5 50 1
SeminalVesicles 510 50 28 8
PenileBulb 590 33 47 12
Non OAR 9869 2886 813 425
Total 15,065 3195 1154 491
Table 2: Prostate structure type distribution in VA-ROQS and VCU datasets.
them to lower case.
3.3.4 Model Selection
After preprocessing the data, the next step is to select the appropriate ma-
chine learning method. We experimented with different types of methods to map the
physician-given structure names to the TG-263 standardized names. The datasets
presented have some unique characteristics that impacted the choices and perfor-
mances of our algorithms. Structure names are very short in size (varying between 4
and 20 characters), which limits the use of complex machine learning algorithms [29].
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TG-263 Standard Name Physician-Given Names in Dataset
Colon Sigmoid, BOWEL LARGE, Bowel, sigmoid
colon, Bowel LG, SIGMOID COLON, colon, Sigmoid
OAR, Bowel NOS, large bowl, Sigmoid AZ, large bowel,
Large Bowel Lg bowel, LG BOWEL, COLON partial, LargeBowel,
Sigmoid-AZ, Bowel Large, Rectosigmoid, Sigmoid
Colon, LARGE BOWEL, SIGMOID08JUN16
FEMORAL LT, Femur L, LFH, Femur LT, Femoral
Head Lt, Femoral Head Lt,Lt Fem Head, FEMUR L,
left femhead, Femur L, L FEM HEAD, Lt Femur, Fe-
mur Head L, Hip Left, Femur-Lt, Hip Left, Femur-Lt,
Femur L Lt Femoral Head, Fem hd neck Lt, Lt Hip, lt fem head,
Femoral Lt, Femoral Head L, FEM HEAD LT, L Fem
Hd,Femur Left, Femur l. , lt femoral hd, Left Femoral
head JPC,
Table 3: Examples of physician-given RT structure names in VA-ROQS dataset.
Standard names on the left and physician-given names on the right.
For better applicability of the machine learning algorithms, we identified the features
from the structure names to build the feature vectors, which are necessary for any
machine learning algorithm.
Since machine learning algorithms work on numerical data, we converted the text
data into numerical features. Numericalization of text data involves two steps [30]:
(1) tokenization or feature set generation and (2) vectorizing the features with feature
weight calculation techniques. We tried multiple feature generation and feature weight
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calculation methods, as discussed next.
We tested the following list of techniques for feature set generation.
1. Bag-of-words (BoW): In this model, text (such as a sentence or a document) is
represented as the bag (multiset) of its words, disregarding grammar and even
word order but keeping multiplicity [31]. The bag-of-words model has also been
used extensively in the NLP domain. For example, bag-of-words features for
the physician-given name “emoral head left” are “femoral”, “head”, and “left”.
2. Word NGram: An NGram is a contiguous sequence of n words from a given
sequence of text. Given a sentence, we can construct a list of NGrams from it
by finding pairs of words that occur next to each other. For example, with a
physician-given name, “femoral head left”, we can construct bi-grams (NGram
of length 2) by finding consecutive pairs of words; “femoral head” and “head
left” are bi-grams.
3. Character NGram: In this model, instead of considering a full token or a term,
a set of continuously occurring characters is used to build the feature set. These
character sets are considered to form NGram features. For example: with the
physician-given name “bladder”, character tri-gram features are “bla”, “lad”,
“add”, “dde”, “der”.
Assigning appropriate weights to individual features as per their relevance in a
given dataset is known as feature weighting. It is generally thought of as a gener-
alization of feature selection, where the presence of a feature serves as the criterion
for its extraction. We used various feature weighting methods to build the feature
vectors, as shown below.
1. Term presence (tp): In this method the presence or absence of a term in the
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given document is encoded as 1 or 0.
2. Term count (tc): This method is an extension of the tp method. Here, term
occurrence is considered as the weight; it denotes the number of times a given
term appears in a document.
3. Term frequency (tf): In this method, the term occurrence is usually normalized
to prevent a bias towards longer documents (which may have a higher term
count regardless of the actual importance of that term in the document) from
giving a measure of the importance of the term t within the particular document
d. Thus we have the term frequency, defined as follows [32, 33].
tft,d = 1 + log tft,d (3.1)
4. Term frequency-inverse document frequency (tf-idf): tf-idf is a numerical statis-
tic that reflects how important a word is to a document in a collection or corpus
[34]. It involves two parts: First is tf, which is defined as in Equation (3.1).
Second is inverse document frequency (idf)), which is a measure of the general
importance of the term (obtained by dividing the total number of documents by






tf-idft,d = tft,d · idft (3.3)
In Equations (3.1)–(3.3), tf is term frequency, df is document frequency, t is
term, d is document, df t is number of documents a term (t) appears in, and N
is the total number of documents.
5. Word embeddings: Words or phrases from the vocabulary are mapped to vectors
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of real numbers. Conceptually, it involves a mathematical embedding from a
space with many dimensions per word to a continuous vector space with a much
lower dimension; word2vec [35], Glove [36], and fastText [37] are some of the
word embedding techniques.
Feature Weighting Example
Here we show the examples of each of these weighting methods. Consider four
physician-given names: (1) large bowel, (2) sigmoid colon, (3) bowel, and (4) bowel
lg . If we consider the bag-of-words model for feature set generation, our feature
set will consist of unique tokens from the above mentioned four names, which are
{ large, bowel, sigmoid, colon, lg }. The total number of documents is four (N =
4) (physician-given names). Below are feature vectors with each of the weighting
methods for physician-given name ”large bowel” as below.
feature Set =
[












0.5 0.5 0 0 0
]
tf − idf =
[
1.301 0.087 0 0 0
]
We used six different classification algorithms—SVM-linear [15], SVM-RBF [16],
k-nearest neighbors (KNN) [18], logistic regression [38], random forest [20], and fast-
Text [37]—for initial model selection. All models were built by using scikit-learn
machine learning library in python [39]. The best model was selected based on their
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performance on the VA-ROQS dataset. Tables 4 and 5 show the performances of
these models for the different feature vector methods. One of the objectives of this
work was to understand the impact of feature weighting techniques on model perfor-
mance. A thorough comparison of feature weighting techniques and their effects on
structure name standardization is beyond the scope of this study. Nevertheless, we
report the observations we made during the initial model selection as below.
Tables 4 and 5 show the machine learning model performance with different
feature weighting methods. We observed that the tp, tc, and tf with all combinations
of ML algorithms produced the same results. We observed that these three feature
weighting techniques produced the same feature vectors, where tp and tc produce the
same vector, and tf is a normalized version of the tc. We believe this is because of the
unique characteristics of our dataset. Instances (physician-given names) are short,
and words within the names are not repeated. The examples shown above indicate
the same. As we know from Equation (3.3), the tf-idf feature weighting technique
takes the global picture of words into account in the calculations, which changes the
weights of the features when compared to other methods. Interestingly, tf-idf did not
perform well when compared to the other weighting methods for both prostate and
lung disease datasets. In comparison with all weighting methods, the word vector
based fastText algorithm consistently outperformed all other algorithms; hence we
selected it to build our final model.
3.3.5 Model Evaluation
An essential part of building a machine learning system is to demonstrate its
quantifiable generalizability. For example, the critical goal of a machine learning
classification algorithm is to create a learning model that accurately predicts the
class labels of unseen data samples. Hence the machine learning model should work
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Features Algorithm Accuracy Precision Recall F1-Score
SVM RBF 0.99 0.96 0.97 0.97
SVM Linear 0.99 0.96 0.97 0.97
tp Random Forest 0.98 0.96 0.97 0.96
Logistic Regression 0.99 0.97 0.97 0.97
KNeighbors 0.97 0.94 0.96 0.95
SVM RBF 0.99 0.96 0.97 0.97
SVM Linear 0.99 0.96 0.97 0.97
tc Random Forest 0.98 0.96 0.97 0.96
Logistic Regression 0.99 0.97 0.97 0.97
KNeighbors 0.98 0.94 0.97 0.95
SVM RBF 0.99 0.96 0.97 0.97
SVM Linear 0.99 0.96 0.97 0.97
tf Random Forest 0.98 0.96 0.97 0.96
Logistic Regression 0.99 0.97 0.97 0.97
KNeighbors 0.98 0.94 0.97 0.95
SVM RBF 0.99 0.97 0.96 0.97
SVM Linear 0.99 0.97 0.97 0.97
tf-idf Random Forest 0.99 0.96 0.97 0.97
Logistic Regression 0.98 0.97 0.96 0.96
KNeighbors 0.98 0.95 0.97 0.96
Word-vectors fastText 0.99 0.97 0.97 0.97
Table 4: Initial Model Selection Results for VA-ROQS Prostate datasets.
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Features Algorithm Accuracy Precision Recall F1-Score
SVM RBF 0.99 0.95 0.92 0.93
SVM Linear 0.99 0.98 1.00 0.99
tp Random Forest 0.99 0.96 0.97 0.96
Logistic Regression 0.99 0.97 0.97 0.97
KNeighbors 0.97 0.88 0.93 0.89
SVM RBF 0.99 0.95 0.92 0.93
SVM Linear 0.99 0.98 1.00 0.99
tc Random Forest 0.99 0.96 0.97 0.96
Logistic Regression 0.99 0.97 0.97 0.97
KNeighbors 0.97 0.88 0.93 0.89
SVM RBF 0.99 0.95 0.92 0.93
SVM Linear 0.99 0.98 1.00 0.99
tf Random Forest 0.99 0.96 0.97 0.96
Logistic Regression 0.99 0.98 0.98 0.98
KNeighbors 0.97 0.88 0.93 0.89
SVM RBF 0.99 0.94 0.94 0.94
SVM Linear 0.99 0.93 0.93 0.92
tf-idf Random Forest 0.99 0.96 0.97 0.96
Logistic Regression 0.99 0.94 0.90 0.92
KNeighbors 0.98 0.89 0.92 0.90
Word-vectors fastText 1.00 1.00 0.99 0.99
Table 5: Initial Model Selection Results for VA-ROQS Lung datasets.
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well for classifying future data.
Model validation is an important step in the machine learning process. Evalu-
ation of a model on the training dataset would result in a biased score. Therefore
the model is evaluated on the held-out set to give an unbiased estimate of model
performance. Just a hold-out set validation is not enough to test the robustness and
finalize the model. It is recommended to validate the model on the entire dataset [40,
41]. One such technique is k-fold cross-validation. To that effect, we validated our
models in three different ways on the VA-ROQS dataset and tested it on the VCU
dataset (external dataset).
Model Validation
1. 70:30: The VA-ROQS dataset was divided into a 70:30 ratio as the training
and validation sets. The split was stratified by TG-263 standard names, which
ensured that an equal percentage of data was taken from each standard name for
training, validation, and testing, thereby avoiding center-based bias in modeling.
2. K -fold: The VA dataset was divided into K -folds in such a way that each
fold was stratified by standard name. The K -1 fold of the data was used for
training, and the remaining fold was for validation. This was repeated until all
folds were validated. We performed 5-fold and 10-fold cross-validation to better
capture the variance in data folds.
3. Center-based: The VA-ROQS dataset came from 40 (n = 40) different treat-
ment centers. Data from 39 (n-1) centers were used for training, and one center’s
data was used for testing. We repeated this process until all centers were tested
based on the model trained on the remaining n-1 centers.
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Model Testing
Once the model is thoroughly validated and finalized, we need to test it on
entirely new data (unseen by the model during training). We built a final model on
the VA-ROQS dataset and tested it on the VCU dataset. One of the reasons we
choose VA-ROQS for training and VCU for testing was to avoid any overlap of data
between the training and test sets.
3.3.6 Evaluation Metrics
The performance of a model can be measured with different evaluation metrics.
However, these metrics need to consider the class (structure labels) distribution to
evaluate the model accurately. The dataset presented has a high level of class im-
balance, as shown in Tables 1 and 2. Hence we evaluated the performance of each
model using four distinct metrics—overall accuracy, macro-averaged precision, recall,
and F1-Score. Overall accuracy simply measures the percentage of OARs in the val-
idation set classified correctly. These evaluation metrics were described in Section
2.5.
3.3.7 fastText Classification Algorithm
The fastText text classification algorithm [37] is an extension of the word2vec
method, which includes three major steps. First, is generating the word vectors;
fastText learns the vector representation of words from subwords (character NGram)
[42]. For example, the word “Bladder” with a character NGram of 3 will have fastText
representations such as “<bl, bla, lad, add, dde, der, er>” wherein < and > are added
to indicate the beginning and end of the word. The technique of breaking the word
into character NGram makes it work well with rare words. This helps to find the
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vector representation of a word, even if it is not seen in training, and this is done
by breaking down the word into character NGrams to get the word embedding. A
subword size can be selected with range minn and maxn, indicating the minimum
and maximum length of the subwords to generate. Along with these, fastText also
considers wordNgrams (word NGram) to build the vector representation. Vector
size is selected by setting the dim parameter. In Section 3.3.8, we explained the
hyperparameter tuning process.
In the second step, word vectors are averaged to form a document vector, and in
our method, it represents the vector representation of the complete RT structure. In
the third and final step, it passes the averaged vectors through a shallow neural net-
work with one hidden layer and uses the softmax function to generate the probability
of a structure is one of the standard RT structures. Figure 9 shows the architecture
of the fastText supervised classification algorithm.
Fig 9: Pictorial representation of fastText supervised classification algorithm.
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3.3.8 fastText Hyperparameter Tuning
After the initial selection of models, we chose fastText for further analysis, as it
performed better than all other models. To further improve the model’s performance,
selecting appropriate hyperparameter values is important. The fastText algorithm has
many hyperparameters, and we chose eight parameters to optimize, which have an
impact on the data dictionary and model training. Out of eight hyperparameters
selected for model tuning, two hyperparameters minn and wordNgrams were kept at
fixed values. wordNgrams selects the number of consecutive individual words while
building a data dictionary. Physician-given names are most likely to have less than
three distinct words; to avoid considering the complete given name as a token, we
set wordNgrams to 2. On the other hand, minn provides the minimum number of
consecutive characters to consider as a token. We set minn to 2 to capture the more
meaningful tokens rather than selecting every character as a token. Table 6 shows
the hyperparameters and values tested.
A total of 15,360 combinations of hyperparameters was generated; each combi-
nation of hyperparameters was used to build a separate model for each disease type,
and so considering the two disease types, overall we created 30,720 models. Models
were evaluated with metrics described in Section 3.3.6 on the validation dataset and
were recorded separately for each of the diseases types. Figures 10 and 11 show the
impact of each hyperparameter on model performance. Boxplots are used to show
the distribution of model performance (F1-Score) for each value of the hyperparame-
ter; the value with the smallest inter-quartile range and highest median was selected.
The hyperparameter value was selected based on its performance on both disease type
data (prostate and lung). The best values for selected hyperparamters are shown in





Fig 10: Hyperaparameter Tuning of fasttext for VA-ROQS Prostate cancer dataset.
(a) dim: size of vector (b) epoch: number of times a model see’s the all of the data
while training, (c) loss, (d) ws: context window size (e) maxn: maximum length of





Fig 11: Hyperaparameter Tuning of fasttext for VA-ROQS Lung cancer dataset. (a)
dim: size of vector (b) epoch: number of times a model see’s the all of the data while
training, (c) loss, (d)ws: context window size (e) maxn: maximum length of character
ngram (f) lr: learning rate.
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3.4 Results
In this section, we present the results of our models for both the VA and VCU
datasets. We built models with combinations of feature sets, feature weighting meth-
ods, and machine learning algorithms. We observed that among all models, the fast-
Text model performed consistently well on our data. Hence we present the detailed
descriptions of results from only the fastText models. Results from the remaining
models are shown in the Appendix B. The macro-averaged precision, recall, F1-Score,
and overall accuracy for both prostate and lung datasets for all the validation types
are shown in Table 7. Individual class level results are shown in Tables 28, 30, 31,
and 29 for prostate and Tables Tables 32, 33, 34, and 35 for lung in the Appendix B.
After fastText was selected as a final model, we tested the robustness of this
method with four different validation types. Each of the validation types tested a
different aspect of our model performance. Below we describe the results for each of
these validation types.
3.4.1 Validation Results
70:30 validation: This validation type was chosen to test the model general-
izability when data was split into 70% for training and 30% for testing. We split
the data such that 70% of the patients from each center were under the training set
and the rest of the patients from each center were under the testing set. We ob-
served that our method was able to generalize well, and our model achieved overall
macro-averaged F1-Scores of 0.97 and 1.0 for prostate and lung datasets respectively.
That indicates that our model was able to predict each label correctly. We also ob-
served that our results were consistent across all classes regardless of class imbalance.







































































































































































































































































































































































































































































































































































































































































































Evaluation Disease Validation Precision Recall F1-Score ACC
Type Type
70:30 0.97 0.97 0.97 0.99
5-fold 0.96 0.96 0.96 0.98
Prostate 10-fold 0.96 0.97 0.96 0.98
Validation VA Center 0.94 0.94 0.94 0.97
(VA-ROQS) 70:30 1.00 0.99 0.99 1.00
5-fold 0.98 0.98 0.98 0.99
Lung 10-fold 0.99 0.99 0.99 0.99
VA Center 0.93 0.93 0.93 0.99
Test Prostate - 0.94 0.99 0.96 0.98
(VCU) Lung - 0.83 0.89 0.86 0.96
Table 7: Disease specific macro-averaged precision, recall, F1-Score, and overall ac-
curacy for validation and test sets.
K -fold validation: With this validation type we checked the performance on
the complete dataset. Here, we split the data into K-folds using a K value of 5. We
observed that the 5-fold cross-validation achieved overall macro-averaged F1-Scores
of 0.96 and 0.98 for prostate and lung datasets respectively. Excellent results from
5-fold validation indicates that our model was able to generalize the overall data and
not just on some random split of the data. We also repeated the same process for 10-
fold cross-validation and observed that the model achieved similar results with 0.96
and 0.99 macro-averaged F1-Scores for prostate and lung respectively. We chose to
present the 5-fold results here, and the 10-fold cross validation results are presented
in the Table 31 for the prostate and Figure 35 in Appendix B for the lung. It is
important to see the consistent performance of each label in all folds. Figure 12b
for the prostate and Figure 13b for the lung shows that our model has performed
consistently well across all folds for each class and provided consistent performance.
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Center-based validation: VA has 40 radiation therapy centers. Even though
they all are under one VA management, we believe that there are some differences in
their practices. Each center operates as an individual institution at the practice level.
In order to test this hypothesis, we trained the model on the data from 39 centers
and tested it on one center and repeated this process until all the centers had been
tested. We observed that the model achieved 0.94 and 0.93 overall macro-average
F1-Scores for the prostate and lung respectively. Although the model performed
well, the performance dropped by 2% for the prostate and around 6% for the lung.
This indicates that our model has high performance, but the inherent variance in
structure naming practices at the different VA centers caused the model to make
some mistakes, which lead to a decrease in performance when compared to the first
two validation types.
3.4.2 Test Results
Once the model is finalized after thorough validation methods, it is imperative
to check the model’s performance on the unseen dataset. Here, the VCU dataset
was used as a test set, which was never used in algorithm selection, model training,
or validation. The final model was built with hyperparameters selected (see Section
3.3.8) on the entire VA-ROQS dataset. By using the VCU dataset as a test set, we
were able to assess two aspects of our model. First, we checked the model’s ability to
generalize on the unseen data. Second, we checked the generalizability on a dataset
from a different source. We observed that our model was able to predict the correct
labels with high macro-averaged F1-Scores of 0.96 and 0.86 for prostate and lung
datasets, respectively as shown in Table 7. However, model performance dropped
when compared to the model validation results, which indicates that although the





Fig 12: VA-ROQS prostate dataset—cross-validation results: (a) VA-ROQS 70:30






Fig 13: VA-ROQS lung dataset—cross-validation results: (a) VA-ROQS 70:30 split






Fig 14: Validation set (VA-ROQS) confusion matrices of different validation types
for both prostate and lung. (a) Prostate 70:30 split validation. (b) Lung 70:30 split
validation. (c) Prostate 5-fold cross-validation. (d) Lung 5-fold cross-validation. (e)
Prostate VA Center cross-validation. (f) Lung VA center cross-validation. Lighter
color indicates better prediction. Diagonal indicates the correctly predicted labels.
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a drop in overall macro-average F1-Score due to the one OAR label BrachialPlexus ;
VCU dataset did not have any OARs labeled BrachialPlexus but our model predicted
the BrachialPlexus L as BrachialPlexus. Even if the number of samples is very few,
macro-averaged metrics give equal importance to all labels and penalize the overall
score regardless of the number of instances of labels in the dataset. Table 8 and Table
9 shows the class-wise results for prostate and lung data. We suspect that it is because
VCU is an academic medical center, unlike the VA, and hence the structure-naming
practices at VCU differ to accommodate the needs of academic hospitals.
(a) (b)
Fig 15: Test set (VCU) confusion matrices. (a) Prostate. (b) Lung. Lighter color
indicates better prediction. Diagonal indicates the correctly predicted labels.
3.5 Discussion
The proposed radiotherapy structure name standardization methodology is sys-
tem agnostic. Each of the validation types we presented on the VA-ROQS data
demonstrates that our model is robust and works well to identify the correct TG-263
standardized names. We also tested our model with data from outside of the VA
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Structure Name Precision Recall F1-Score Support
Bladder 1.00 1.00 1.00 50
External 1.00 1.00 1.00 50
Femur L 1.00 1.00 1.00 32
Femur R 1.00 1.00 1.00 31
LargeBowel 0.83 1.00 0.91 5
Non OAR 1.00 0.97 0.98 833
PenileBulb 1.00 0.96 0.98 49
Rectum 1.00 1.00 1.00 50
SeminalVesicles 1.00 1.00 1.00 28
SmallBowel 0.53 0.96 0.68 26
accuracy 0.98 0.98 0.98 1154
macro avg 0.94 0.99 0.96 1154
weighted avg 0.99 0.98 0.98 1154
Table 8: VCU Test Set results of Prostate structures.
Structure Name Precision Recall F1-Score Support
BrachialPlexus 0.00 0.00 0.00 7
BrachialPlexus L 0.75 1.00 0.86 3
BrachialPlexus R 1.00 1.00 1.00 5
Carina 1.00 1.00 1.00 33
Esophagus 1.00 0.98 0.99 47
Heart 0.98 1.00 0.99 46
Lung L 0.82 0.92 0.87 25
Lung R 0.74 1.00 0.85 20
Lungs 0.85 0.95 0.90 37
Non OAR 0.98 0.97 0.98 586
SpinalCord 0.96 0.98 0.97 49
accuracy 0.96 0.96 0.96 858
macro avg 0.83 0.89 0.85 858
weighted avg 0.96 0.96 0.96 858
Table 9: VCU Test Set results of Lung structures.
system (VCU dataset) which shows that our method works well for data from other
institutions.
For the prostate RT structures, we observed that the majority of mistakes made
by the model were in classifying SmallBowel and LargeBowel. This confusion is
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attributed to the fact that the same name can be used for both anatomical structures.
In Table 10, we can see that “bowel” is used to label both SmallBowel and LargeBowel.
In the VCU Lung dataset validation, accuracy and macro-average F1-Score dropped
when compared to the 70:30 split validation. This drop was caused by the misclassi-
fication of the lung and brachial plexus related structures, as shown in Table 11.
3.5.1 Error Analysis
Confusion matrices for all validation types on validation dataset (VA-ROQS)
are shown in Figure 15 and for test dataset (VCU) in Figure 14. We performed
an error analysis on the test set to understand our model’s ability to generalize on
unseen data. Error analysis provides insights into the reasoning behind the failure
of the model prediction. In this work, a false positive is more expensive than a false
negative. Although, this is a multiclass classification problem, wrongly predicted
OAR is more expensive than a wrongly predicted Non OAR. To this end, we divided
classification errors into three main categories.
• Type I: When the structure was OAR but predicted as Non OAR.
• Type II: When the structure was OAR but predicted as the wrong OAR.
• Type III: When the structure was Non OAR but predicted as OAR.
Type II and III errors are expensive when compared to the type I error, as
they produce false-positive OAR. Looking at the predicted and standard labels for
physician-given names, we can infer that there is a pattern to errors for a few struc-
tures. Table 10 shows the errors made on VCU Prostate dataset. We observe that
the majority of the errors come from Type I. The major error was due to the lack of
signal in the text label. Just looking at the structure name “bowel” and inferring the
“SmallBowel” or “LargeBowel” structures is difficult even for experts.
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Error Type Physician TG-263 Predicted Count
Given Name Standard Name Name
Type I bowel LargeBowel Non OAR 1
bowel SmallBowel Non OAR 22
Type II nonptvpenilebulb Non OAR PenileBulb 2
small bowel Non OAR SmallBowel 1
Table 10: Error analysis of VCU dataset prostate structure.
Error Type Physician TG-263 Predicted Count
Given Name Standard Name Name
bilatlungs Lungs Non OAR 5
ptv Lungs Non OAR 1
lung-l Lung L Non OAR 1
lung l1 Lung L Non OAR 4
Type I lung-r Lung R Non OAR 2
lung r1 Lung R Non OAR 4
spinal column SpinalCord Non OAR 1
spine SpinalCord Non OAR 1
brachial plexus BrachialPlexus L BrachialPlexus 1
Type II esophagus Heart Esophagus 1
lung Lung R Lungs 1
ipsi lung Non OAR Lung L 1
left lung Non OAR Lung L 1
brachial plexus Non OAR BrachialPlexus 1
Type III brachial plexus Non OAR BrachialPlexus 2
lung Non OAR Lungs 1
plexus Non OAR BrachialPlexus 3
t7 cord Non OAR SpinalCord 1
Table 11: Error analysis of VCU dataset lung structure names.
In case of Lung, we see that there are many more Type II an III errors made by
the model. Table 11 shows all the errors made on the VCU Lung dataset. We can see
that majority of the errors were made while predicting the structures related to the
lungs (Lung L, Lung R, or Lungs) and brachial plexus. For lung-related structures
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we see that names containing numerical characters are most likely to be predicted as
Non OARs, as it is common for Non OAR structures to contain numerical characters.
For brachial plexus related structures, we can see that names containing “Plexus” are
predicted as BrachialPlexus if there is no other information found to determine it
as left or right BrachialPlexus. This also indicates the model errors due to the lack
of signal in the input data. We also looked at the errors made by the model from
holdout set (70:30 split) validation results. Tables 12 and 13 show the errors made on
VA validation set for prostate and lung datasets respectively. We observed a similar
pattern of errors for the prostate; the major confusion is between “SmallBowel” and
“LargeBowel”.
3.5.2 Comparison with Previous Works
Our work differs in many ways when compared to the most recent proposed
approaches in the research community. Schuler et al. reported that their approach
resulted in a 99% relabel rate [23], but it requires the mappings from the domain
expert from the same institute where data are collected. In contrast, our method
provides the same success rate with the added advantage of working on arbitrary
physician-given names from multiple institutes. Our work is scalable and general-
izable to the external dataset. Two other works proposed machine learning based
structure name standardization using geometric information [26, 27]; both of those
projects reported high accuracy. However, both of them did not use all the structures;
instead they used only OARs. Our approach takes all possible structures into account
and hence will work on real-world clinical datasets. However, due to the aforemen-
tioned limitations of the related work, it is not possible to perform a direct comparison
between the accuracies from our approach and those from related work. It should
also be noted that our proposed approach is the very first text mining based method
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to automatically standardize arbitrary structure names from the DICOM dataset.
Error Type Physician TG-263 Predicted Count
Given Name Standard Name Name
bowel LargeBowel Non OAR 5
bowel large LargeBowel Non OAR 1
bowel, large LargeBowel Non OAR 1
bowel SmallBowel Non OAR 6
bowel (partial) SmallBowel Non OAR 1
Type-I bowel-ptv sigm SmallBowel Non OAR 1
fem hd neck l Femur L Non OAR 1
p bulb control PenileBulb Non OAR 1
rectum om Rectum Non OAR 1
rectum wm Rectum Non OAR 1
bladder min Bladder Non OAR 1
Type-II sigmoid SmallBowel LargeBowel 1
sigmoid Non OAR LargeBowel 5
large bowel Non OAR LargeBowel 1
colon Non OAR LargeBowel 1
small bowel Non OAR SmallBowel 4
sm bowel Non OAR SmallBowel 3
whole rectum Non OAR Rectum 1
bladder, nos Non OAR Bladder 3
Type-III bladder1 Non OAR Bladder 1
femoral head r Non OAR Femur R 1
femur r Non OAR Femur R 1
vesicle bed Non OAR SeminalVesicles 1
Table 12: Error analysis of VA-ROQS prostate structure names with 70:30 validation.
3.5.3 Limitations
Our proposed model has three limitations. Firstly, we are only predicting the
identities of the OARs and labeling them with standard names. However, the target
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Error Type Physician TG-263 Predicted Count
Given Name Standard Name Name
total lung Lungs Non OAR 2
Type I spinalcanal SpinalCord Non OAR 2
cord 0 SpinalCord Non OAR 1
esophagus-kl Esophagus Non OAR 1
es Non OAR Esophagus 1
cord Non OAR SpinalCord 1
Type III cord3 Non OAR SpinalCord 2
l lung lymph Non OAR Lung L 1
heart2 Non OAR Heart 1
Table 13: Error analysis of VA-ROQS Lung structure names with 70:30 validation.
(tumors) and PRVs are important structures and identifying and labeling them is
also crucial for treatment delivery quality assessment. Secondly, we demonstrated
that we can train on data from one institution and predict data from another. Our
model is also language dependent, as it was trained only on structure names written
in English. We believe the model pipeline will work for any language, but inter
language models are only possible if they are trained on a mixture of languages.
Thirdly, the ML pipeline from data preprocessing to prediction works as a standalone
system. In the future, we plan to create a seamless enterprise informatics platform
that can automatically collect data from the treatment planning systems and perform
automatic structure name standardization on retrospective data.
3.6 Conclusion
In this chapter, we presented an ML approach to standardize the radiother-
apy structure names using physician-given names. We observed that the fastText
algorithm works best when compared to other feature weighting and classification
algorithms. Our method was evaluated with the data from 40 VA radiotherapy cen-
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ters and tested on an external dataset from VCU. We demonstrated that our method
works well on multiple disease sites and is also generalizable. To the best of our knowl-
edge, this is the first and the only model using the physician-given name to predict
the TG-263 standard names using NLP and ML based methods. We also observed
that our approach fails in certain conditions, when enough information is not available
for the model to infer the correct label. Our approach can be augmented with other
available information, such as geometric information of structures. We believe that
the proposed structure names standardization methods can help with big data ana-
lytics in the radiation therapy domain using population-derived datasets, including
standardization of the treatment planning process, clinical decision support systems,
treatment quality improvement programs, and hypothesis-driven clinical research.
Contribution summary: In this chapter, we presented a text mining based ap-
proach for structure name standardization using physician-given names. Specific con-
tributions of this chapter are as follows.
1. We present a machine learning approach to standardize the radiotherapy struc-
ture names that can automatically convert the arbitrary physician-given struc-
ture names to the domain wide TG-263 based nomenclature.
2. We demonstrate that a relatively small amount of data from each treatment
center is enough to build a generalizable machine learning model, which a simple
text mapping cannot achieve.
3. We establish that our proposed approach is disease site agnostic, i.e., it can be
used on multiple disease sites.
4. We also demonstrate that physician-given names hold enough information about
the structures that can be utilized to predict the standard names in TG-263.
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5. Finally, we create a scalable approach that requires little to no preprocessing.
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CHAPTER 4
MULTI-VIEW DATA INTEGRATION METHODS FOR
RADIOTHERAPY STRUCTURE NAME STANDARDIZATION
Fig 16: Thesis contribution chart, Chapter 4 contributions are highlighted.
4.1 Introduction
In Chapter 3, we presented structure name standardization using fastText doc-
ument embeddings. Although our model had performed well, it made some wrong
predictions. Our analysis showed that it is because of the use of the same labels
for different structures. For example, some radiation oncologists used Bowel to label
SmallBowel, and some had used it to label LargeBowel, which creates confusion when
data from all patients is used to build the model. The use of the same name for
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different structures may be because of the difference in naming practices at different
VHA centers. To address such issues, we investigated the use of geometric infor-
mation of structures for automatically identifying the standard structure names. It
was evident from the results shown here that just geometric information may not be
enough; hence we also investigated different approaches to integrate the textual labels
and geometric information of structures. Such geometric information of structures
provides a different view of the structures, which additionally helps in differentiating
structures when physician-given names are the same. Since our datasets (views) are
heterogeneous, we integrated the approaches at the intermediate and last stages of
the machine learning pipeline.
4.2 Methods and Materials
4.2.1 Dataset
Dataset used in this chapter is the same as in Chapter 3 with the following
two differences. First, Chapter 3’s objective was to identify OARs when arbitrary
structure names were given. In this chapter our objective is to identify “PTV” (target
structure) along with OARs. Hence, the following prostate and lung structures were
considered in this chapter:
Prostate Structures: Rectum, Bladder, Femur L, Femur R, LargerBowel, Small-
Bowel, PTV
Lung structures: Esophagus, Heart, SpinalCord, Brachial Plexus, PTV
VA-ROQS Dataset: We have utilized the same VA-ROQS data used in Chap-
ter 3, however we considered only structures required for the VA-ROQS project.
VCU Dataset: A new 50 set of patients for each prostate and lung cancer were
59
selected from VCU databases. These were entirely new patients with no overlap com-
pared to the patients considered for VCU in “Structure Name Standardization using
Physician-given names” ( Chapter 3). The annotation process explained in Section
3.3.1 is followed to annotate the new dataset. Table 14 shows the distribution of lung
and prostate structures for the VA-ROQS and VCU datasets.
4.2.2 Creation of Structure Set
Once a patient has been diagnosed with cancer and radiotherapy is prescribed
as part of the treatment, a patient model needs to be created to determine the radia-
tion dose to the target volume, OARs, and the coverage volume. To accomplish this
purpose, imaging datasets are acquired. The most commonly used imaging dataset
is Computed Tomography (CT), which provides tissue density information and the
patient model information by rendering the patient’s anatomy. A clinician will delin-
eate the target/tumor region, OARs, and any other structures deemed necessary for
the current case on this acquired dataset. This delineation is usually done within the
TPS software, which will allow for the creation of the dose delivery treatment plan.
Figure 17 shows the axial, coronal and sagital cut sections of a prostate cancer
CT, overlaid with several delineated structures. The imaging and structure set infor-
mation is in the Digital Imaging and Communications in Medicine (DICOM) format
which is the industry standard for the storage and transmission of medical imaging
data. This data is traditionally stored as slices on the axial axis but can be rendered
on any axis. A clinician will delineate any necessary structures using the delineation
tool-sets in the TPS software; often by adding individual points or by using a free-
hand drawing tool to create a closed polygon. For a given structure, this process is
performed on each imaging slice until the delineation is complete.
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VA-ROQS VCU
Non Standard Name Non Standard Name
Standard Name Structure Count Unique Count Structure Count Unique Count
Brachial Plexus 108 44 4 4
Esophagus 613 26 47 3
Heart 670 20 45 2
Other (Lung) 10,292 3,639 775 317
SpinalCord 681 37 48 6
PTV (Lung) 680 286 36 4
Lung Total 13,044 4,052 955 336
Bladder 609 10 50 3
Femur R 700 62 29 14
Femur L 694 59 29 13
Rectum 719 14 50 3
SmallBowel 250 40 49 10
LargeBowel 341 34 0 0
Other (Prostate) 11,038 2,799 980 434
PTV (Prostate) 714 236 38 16
Prostate Total 15,065 3,254 1,225 493
Grand Totals 28,109 7,306 2,180 829
Table 14: Lung structure type distribution in VA-ROQS and VCU dataset.
For the same patient, Figure 18 shows the planning target volume (PTV) (green)
and multiple planning related structures (red). The PTV represents the region that
will be receiving the prescribed radiation dose. It is also common to have other
structures that are very similar to the PTV as presented here, and may include
a clinical target volume (CTV), gross tumor volume (GTV), or expansions of the
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Fig 17: Planning CT from a prostate cancer patient with the following delineated
structures: Bladder (yellow), Rectum (blue), Left and Right Femurs (orange), Small
Bowel (aqua), PTV (green).
PTV. Also presented in this figure are rings, used for helping to guide the TPS dose
optimization process, and implanted marker seeds.
62
Fig 18: The PTV (green) and multiple other planning related structures (red) delin-
eated on a planning image. These planning structures include rings, implanted seeds,
and several interpretations of the tumor volume.
4.2.3 Data Preprocessing
Textual Data Preparation
Structure names are short and have a limited character set to use, and the
available character set is vendor dependent. As shown in Table 3, even though there
is high variability in physician-given structure names for most of the structure types,
the character set used is limited. Preprocessing methods need to be selected to ensure
that critical information is retained; losing the information might negatively affect
the ability to standardize the structure names with high fidelity. Hence, we decided
to keep the preprocessing of physician-given names to a minimum by just converting
them to lower case.
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(a) A transverse slice of the origi-
nal planning image with the blad-
der structure shown in yellow.
(b) Polygon points from the DI-
COM bladder structure set delin-
eation. These individual points
are interpolated on to the stan-
dardized bitmap volume.
(c) Each sequential point is con-
nected to form a close polygon.
(d) The close polygon is flood
filled to create a solid structure.
(e) A density threshold is applied
to the planning image such that
only voxels that belonged to bony
anatomy remain.
(f) Structure set (white) and
bony anatomy (grey) data shown
together with the same frame of
reference.




The following process, shown in Figure 19, takes the DICOM structure set and
imaging data and converts it into features vectors to be used as input for the clas-
sification algorithms. Figure 19a shows an original DICOM planning image and its
associated structure set. The bladder structure delineation is shown in yellow.
Since the planning images available in our dataset did not have consistent voxel
count, voxel resolution or origins, a standard grid was needed so that all structure sets
could be stored in a consistent manner. The standard grid chosen for this purpose
was 96 x 96 x 48 voxels and with a voxel resolution of 2mm x 2mm x 3mm. These
parameters were chosen by manually inspecting a number of bitmap examples from
each structure type to verify that the bounding box was large enough to cover the
structures of interest. It should be noted that this manual step is needed only once as
all structure volumes will be interpolated in the same bounding box. Future work is
required to determine if such a one-size-fits-all based solution is sufficient, especially
considering large structures like the entire lungs. Each original planning image and
structure set was programmatically shifted such that the geometric center of the given
structure was aligned to the geometric center of this standardized grid.
The automated workflow for creating feature vectors from the imaging and struc-
ture set data is demonstrated using one prostate patient as shown in Figure 19a. For
each individual structure in the dataset, an empty three-dimensional bitmap object
was created with the standard grid dimensions as defined above. Each polygon point
in the DICOM structure set is mapped to its corresponding voxel in the new bitmap
with a value of 1 as shown in Figure 19b. Then for each transverse slice of the bitmap,
the sequential points were connected with new line segments which results in one or
more closed polygons per slice as shown in Figure 19c. A flood fill algorithm [43]
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was then run on each closed polygon to set all interior values to 1 resulting in a solid
bitmap structure shown in Figure 19d. Voxels belonging to the structure in question
would then have the value of 1 and all other voxels would remain as 0. The proce-
dure used for generating these bitmaps was derived from the Research Computing
Framework package [44].
In addition to the structure set data, imaging data was also used to add spatial
context to the location of each structure in the human anatomy. A density threshold
was applied to each planning image such that voxels with Hounsfield units (HU) above
1,300 were set to 1 and all others set to 0, leaving only the bony anatomy. While
bone density starts around 1,050 HU [45], we have chosen a slightly higher value to
focus on the gross skeletal structure and reduce noise from borderline tissue. The
resulting bony image was then interpolated to the same standardized grid used by
the structures so that both data types were properly aligned. Figure 19e shows just
the bony anatomy and Figure 19f shows the bony anatomy and structure set data
combined.
To create feature vectors, the 96 x 96 x 48 bitmap object was stretched out into
a 442,368 x 1 vector by simply creating an array of each voxel value with increasing
x, y, z axis indices. From this bitmap creation process, two datasets per disease site
were created: Without Bones and With Bones.
• Without Bones: The feature vectors were created with only structure set
data as shown in Figure 19d. The total length of the feature vector is 442,368.
• With Bones: The feature were created by appending the No Bones feature
vectors with the bony anatomy data as shown in Figure 19f. The total length
of the feature vector is 884,736.
Very long feature vectors make the model training phase slow and susceptible
66
to the Curse of Dimensionality [46]. One popular solution to this problem is to per-
form feature reduction by either removing features that are not strongly influencing
predictions or condensing multiple features in such a way that still preserves impor-
tance. We have chosen to use truncated singular value decomposition (SVD) as it
uses much smaller matrix multiplications when compared to methods like principal
component analysis (PCA) or standard SVD [47]. This approach can approximate
the input m×n matrix as [m×k]× [k×n] where k is the numerical rank [48]. When
testing both methods, the truncated SVD ran faster and required less memory while
still producing an explained variance within 0.1% of the result from PCA.
Figure 20 shows the explained variance of the disease sites for the Without Bones
and With Bones datasets. All cases show a similar pattern and the cumulative vari-
ance curves start to flatten out around 100 features. For that reason, we have chosen
100 as the number of SVD features to use in our experiments as increasing the ex-
plained variance by more than a few percent would require at least doubling the total
number of features. Initial tests using up to 1,000 SVD features did not improve
classifier accuracies (data not shown). The anonymized patient identifier, physician
specified label, and the TG-263 standardized label for each structure were added as
features, not for model training, but for patient filtering and assessing the model
accuracy.
This pipeline can be fully automated allowing for the processing of large Radi-
ation Oncology datasets. While the disease specific bounding boxes should be set
manually, it only needs to be done once while all the other modules are done pro-
grammatically.
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Fig 20: Cumulative explained variance from the number of features created by the
SVD process. We have chosen the top 100 features in all models.
4.2.4 Model Selection
4.2.4.1 Single-View
Dataset used in this work is heterogeneous in nature. To properly compare the
advantages of utilizing the multi-view heterogeneous data, we built the best possible
model with single-view separately. In our previous work, we have thoroughly inves-
tigated the different algorithms for standardizing radiotherapy structure names with
physician-given names [3] and geometric information [4]. Single-view model selection
details are as below.
• Text data (Physician-Given Structure Names): We built structure name stan-
dardization models using the combinations of different feature extraction tech-
niques, feature-weighting, and ML-algorithms. We tested NGram (uni-gram,
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bi-gram, and tri-grams), character NGrams, and word embedding techniques
for feature extraction. For feature weighting, we tried with term presence (tp),
term count (tc), term frequency (tf), and term frequency-inverse document fre-
quency (tf-idf) techniques. Finally we compared the six different ML classifica-
tion algorithms —SVM-linear [15], SVM-RBF [16], k-nearest neighbors (KNN)
[18], logistic regression [38], random forest [20], and fastText [37]—for initial
model selection. All models were built by using scikit-learn machine learning
library in python [39]. Finally, we selected the fastText algorithm for automati-
cally identifying the standard structure names using the physician-given names
because it had highest F1-Score in comparison with other algorithms.
• Image data (3D geometric information of structures): In our prior work, we
have also investigated the radiotherapy structure name standardization using
geometric information. In order to extract geometric information, we converted
the geometric information into binary vectors and selected top 100 components
with SVD algorithm. After thoroughly evaluating different algorithms, we used
the RF classification algorithm to build our final model because it provided the
best F1-Score.
4.2.4.2 Intermediate Integration
Intermediate Integration involves transforming the all view data into similar
feature space and combining them (concatenating) into one. We utilized different
techniques to transform them into a similar feature space as discussed below.
• Image Data Transformation: We used truncated singular value decomposition
(SVD) as it uses much smaller matrix multiplications when compared to meth-
ods like principal component analysis (PCA) or standard SVD [47]. When
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testing both methods, the truncated SVD ran faster and required less memory
while still producing an explained variance within 0.1% of the result from PCA.
We used the first 50 features from this feature set.
• Text Data Transformation: We used fastText algorithm to generate the embed-
dings (numerical representation) of size 200 for each physician-given structure
name.
Thus, a final vector of size 250 is generated by concatenating feature vectors
from each view (image and text). This vector is fed into the ML algorithm. We chose
SVM with linear kernel to build the final classification model. Figure 21 shows the
pictorial representation of our proposed intermediate integration method.
Fig 21: Intermediate stage integration method for structure name standardization.
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4.2.4.3 Late Integration
In late integration, each view is analyzed separately and the results are then
integrated to generate the final result. It is also known as model based integration.
Integrating at a late stage has an advantage over other types of integration; the best
algorithm can be selected to build a model based on the data type and each model
can be run in parallel. In this work, we used different algorithms to build the models
for each view. A prediction probability vector is generated for each sample from each
model instead of a class prediction. The size of the prediction probability vector is
equal to the number of classes in the dataset; in this scenario, it is eight classes for
prostate and six classes for the lung dataset. The result vector from each view is then
combined to generate the final prediction probabilities. These prediction probabilities
are used for the final class prediction.
We used two techniques to combine the prediction probabilities from each view.
• Average (AVG): We created the final prediction probability vector by adding
element-wise from each view and dividing it by the number of views. The final
class is selected whose AVG probability is the highest.
• Maximum (MAX): In this technique, we selected the maximum probability from
each view such that the resulting vector contains the maximum for each class
from all the views. The final class is predicted by selecting the class from this
resultant vector with the highest probability.
4.2.5 Model Evaluation
An essential part of building a machine learning system is to demonstrate its
quantifiable generalizability. For example, the critical goal of a machine learning
classification algorithm is to create a learning model that accurately predicts the
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Fig 22: Late integration method for structure name standardization.
class labels of unseen data samples; this ensures that the machine learning model
should work well for classifying future data.
Model validation is another important step in the machine learning process as
explained before and we again used k-fold cross-validation. We divided the VA-ROQS
dataset into training and testing datasets. We randomly selected data from 30 centers
for training and remaining 10 centers data are for testing. We further divided the VA-
ROQS dataset into 70:30 ratio as training and validation sets. Along with VA-ROQS




• Hold-out set validation: The VA-ROQS dataset was divided into a 70:30
ratio as the Training and Validation sets. The split is stratified by TG-263
standard names, which ensures that an equal percent of data is taken from each
standard name for training, validation, and testing, thus avoiding center-based
bias in modeling.
• VA Center Based Cross-validation: The data from randomly selected 30
VA-ROQS centers is used to validate the data from each center separately. Data
from 29 (n-1) centers were used for training, and the remaining one center data
for validation. We repeated this process until all centers are validated.
Model Testing
Once the model is thoroughly validated and finalized, we need to test it on
entirely new data (unseen by the model during training). We built a final model on
the data from 30 VA-ROQS centers and we tested it with two datasets: VA-ROQS
test set (data from 10 centers) and the VCU dataset.
• VA Center Based Test: The data from randomly selected 30 VA centers is
used for training and 10 centers for testing. We tested each center separately
and results are reported to show the generalizability of model across multiple
centers. We used the data from 10 VA centers as a test set to show that our
model is able to predict the labels correctly from multiple centers.
• VCU Test: We used data from 30 VA centers for training the model and tested
it on the VCU dataset. This model testing with VCU dataset shows the our
model’s ability to generalize on a completely external dataset.
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4.3 Results
In this section, we present the results of our experiments. The results are divided
into three subsections: Singe-view, Intermediate Integration, and Late Integration
results.
4.3.1 Single-View
In the single-view approach, we built two separate models with physician-given
structure names and geometric information of structures. We observed that the model
utilizing the structure names consistently out performed the models built utilizing
geometric information. Table 15 and 16 shows the model performance for the VCU
and VA-ROQS datasets. We observed that the text based model has precision of
0.778 for VCU prostate dataset and 0.855 for VCU lung dataset. Figures 23 and
24 shows the confusion matrix for both VCU and VA-ROQS dataset. VCU prostate
dataset has no instances of “large bowel” structures in dataset, but model predicted
the “large bowel” for three structures. A macro-averaged metric penalizes equally
regardless of number of samples in each individual class. In the VCU lung dataset
there are only four “BrachialPlexus” structures but our model predicted the 9 false
positives.
4.3.2 Intermediate Integration
In this method, we transformed the structure names and geometric information
into similar feature space. We applied truncated SVD and selected top 50 components,
and structure name word embedding of size 200 using fastText algorithm. These two
features space from different view are then concatenated for training and testing. We




Fig 23: Single View Results: (a) VA-ROQS Prostate Text Based featuress (b) VA-
ROQS Lung Text features. (c) VCU Prostate Image feature (d) VCU Lung Image
features. Darker color indicates better prediction. Diagonal indicates the correctly
predicted labels.
Table 15 shows the macro-averaged precision, recall, and F1-Score for intermediate




Fig 24: Single View Results: (a) VCU Prostate Text Based features (b) VA-ROQS
Lung Text features. (c) VCU Prostate Image feature (d) VCU Lung Image features.
Darker color indicates better prediction. Diagonal indicates the correctly predicted
labels.
on VA-ROQS and VCU datasets. Precision is higher than the single view models for
three out of four datasets; the overall F1-Score is also higher for the VCU prostate
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and lung datasets. Increase in precision indicates that the model can predict fewer
number of false positives for OAR and target structures. Figure 27 shows the confu-
sion matrices for prostate and lung structures in VA-ROQS and VCU datasets. We
can observe that the Intermediate integration method consistently reduces the false
positives for all OAR and target structures and increased the false positives in the
other structures.
4.3.3 Late Integration
Table 16 shows the macro-averaged precision, recall, and F1-Score for the pro-
posed late integration method. We noticed that in the late integration method with
MAX probability selection, the precision is better than the single view models for
both prostate and lung VCU dataset. However, the recall and F1-Score dropped. We
also observed that using the MAX scores on the VA-ROQS prostate dataset, precision
is increased by 0.07 but recall and F1-Score are negatively affected. Overall, the late
integration with MAX scores exhibited a negative affect on the VA-ROQS dataset.
Figure 26 and 27 shows the confusion matrices for the lung and prostate datasets
respectively.
4.4 Discussion
4.4.1 Strengths and Limitations
In this chapter, we proposed novel approaches to standardize the radiotherapy
structure names using the heterogeneous prostate and lung radiotherapy structures.
We demonstrated that our multi-view integration approach improves the standardiza-
tion process. Structure delineation generates significantly imbalanced datasets, but
our approach can overcome the data imbalance issues thereby demonstrating that
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Datasete Disease Data Type Precision Recall F1-Score Acc
MLB 0.110 0.140 0.130 0.800
Text 0.778 0.730 0.740 0.927
Prostate Image 0.710 0.476 0.519 0.870
Test combined 0.778 0.792 0.782 0.941
MLB 0.140 0.170 0.150 0.810
(VCU) Text 0.830 0.981 0.873 0.969
Lung Image 0.610 0.565 0.585 0.918
combined 0.855 0.895 0.873 0.971
MLB 0.09 0.120 0.110 0.730
Text 0.890 0.866 0.872 0.930
Prostate Image 0.758 0.579 0.619 0.856
Test combined 0.848 0.897 0.864 0.932
MLB 0.130 0.170 0.150 0.780
(VA-ROQS) Text 0.921 0.874 0.893 0.950
Lung Image 0.825 0.694 0.708 0.916
combined 0.939 0.741 0.778 0.943
Table 15: Intermediate Integration - Disease specific macro-averaged Precision, Re-
call, F1-Score, and Overall Accuracy. MLB: Majority Label Baseline.
the proposed approaches can work on real-world datasets. However, our proposed





Fig 25: Intermediate Integration for VA-ROQS and VCU Lung Dataset Confusion
Matrix. (a) Text Based features (b) Image features. (c) AVG of predictions. (d)
MAX of two prediction. Darker color indicates better prediction. Diagonal indicates
the correctly predicted labels.
Clinical Limitation
• So far, we were able to identify only OARs and Target (PTV) structures. Al-




Fig 26: Late Integration Confusion Matrix for VA-ROQS and VCU Lung Datasets:
(a) VA-ROQS Lung AVG Integration.(b) VA-ROQS Lung MAX Integration. (c) VCU
Lung AVG Integration. (d) VCU Lung MAX Integration. Darker color indicates
better prediction. Diagonal indicates the correctly predicted labels.
of structures, such as PRV and derived structures. To fully standardize the data,




Fig 27: Late Integration Confusion Matrix for VA-ROQS and VCU Prostate Datasets:
(a) VA-ROQS Prostate AVG Integration. (b) VA-ROQS Prostate MAX Integration.
(c) VCU Prostate AVG Integration. (d) VCU Prostate MAX Integration. Darker
color indicates better prediction. Diagonal indicates the correctly predicted labels.
• The OARs were selected based on the requirements of the VA-ROQS project
whose primary focus was treatment quality assessment based on the specific
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Dataset Disease DataType Precision Recall F1-Score Acc
MLB 0.110 0.140 0.130 0.800
Text 0.778 0.730 0.740 0.927
Image 0.710 0.476 0.519 0.870
Prostate Avg 0.802 0.685 0.719 0.929
Test Max 0.801 0.708 0.739 0.936
MLB 0.140 0.170 0.150 0.810
(VCU) Text 0.830 0.981 0.873 0.969
Image 0.610 0.565 0.585 0.918
Lung Avg 0.858 0.807 0.811 0.964
Max 0.849 0.810 0.806 0.963
MLB 0.090 0.120 0.110 0.730
Text 0.890 0.866 0.872 0.930
Image 0.758 0.579 0.619 0.856
Prostate Avg 0.897 0.836 0.856 0.930
Test Max 0.897 0.848 0.864 0.930
MLB 0.130 0.170 0.150 0.780
(VA-ROQS) Text 0.921 0.874 0.893 0.950
Image 0.825 0.694 0.708 0.916
Lung Avg 0.918 0.840 0.868 0.964
Max 0.916 0.840 0.867 0.945
Table 16: Late Integration - Disease specific macro-averaged Precision, Recall, F1-
Score, and Overall Accuracy. MLB: Majority Label Baseline.
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quality metrics; analysis of our datasets have shown that radiation oncologists
have delineated many other OAR structures e.g., Kidney and Liver structure
in prostate cancer. To truly build the generalized system that can identify
all possible structures, the dataset needs to identify all correctly labeled OAR
structures, and not just the significant OAR structures.
Methodological limitations
• Extraction of 3D volumes of structures requires selecting the bounding box size
to make sure it covers the biggest possible structure in any given disease. Al-
though, it is a one time step needed at the beginning of the dataset preparation,
it does add an overhead in the complete automation of the pipeline.
• In recent years, deep learning algorithms such as Convolutional Neural Networks
(CNN) have worked best for image based data classification. We plan to extend
our pipeline to integrate CNN based image classification methods in the multi-
view integration approach.
• It is difficult to capture the image semantics by turning images into a single
vector and taking the top 50 components from it.
• We have extracted the structures fitted inside the bounding boxes. Using just
structures information and discarding the other surrounding structures and
anatomical information negatively affects the model performance.
• In late integration, we have tested only AVG and MAX for combining the data.
This gives equal importance to both the Text and Geometric data. As we have
seen from the single-view results, the geometric information model performed
poorly when compared to the text based single view model. Hence we surmise
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that a weighted average technique to integrate the results from the different
views might produce better results.
4.5 Conclusion
In this chapter, we presented two types of multi-view integration methods: inter-
mediate and late integration methods for structure name standardization. We utilized
the physician-given names and geometric information of structures. We observed that
the intermediate integration methods improves the overall performance of the models
while late integraiton helps in reducing the false negatives. We tested our approach
by training it on data from 30 VA RT centers and testing it on 10 VA RT centers and
the VCU dataset. We demonstrated that our method works well on multiple disease
sites and is also generalizable. We believe that the multi-view integration methods are
best suited for structure name standardization, as they make the best use of different
information to avoid the confusion. High VA-ROQS test set performance indicates
that our approach was able to generalize very well within the VA system. Whereas
excellent performance on VCU dataset suggests the model’s ability to generalize well
on the data from outside the VA systems
Contribution summary: In this chapter we address the limitations of structure
name standardization using solely physician-given names and present an approach to
combine the physician-given names with the geometric information of structures for
structure name standardization. Specific contributions of this chapter are as follows.
1. We demonstrate that the use of bony anatomy information along with structures
helps in the standardization process using geometric information.
2. We show that even target structure can be identified along with the Organs-at-
Risk (OARs) with the physician-given names.
84
3. We demonstrate that it is still challenging to predict the standard name with
just geometric information in real-world clinical datasets.
4. We finally demonstrate that integrating physician-given structure names with




AUTOMATIC INCIDENT TRIAGE IN RADIATION ONCOLOGY -
INCIDENT LEARNING SYSTEM
Fig 28: Thesis contribution, Chapter 5 contribution are highlighted.
5.1 Introduction
The radiation therapy (RT) cancer treatment speciality involves coordinated in-
teractions between various clinical staff such as, dosimetrists, physicists, radiation
therapists, nurses, and physicians. However, misadministration of RT can lead to po-
tentially severe consequences [49, 50]. High-risk industries, such as the aviation and
nuclear power industries [51], have demonstrated that the incident learning system
can prevent such errors. The American Society for Radiation Oncology (ASTRO)
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and American Association of Physicist in Medicine (AAPM) are professional soci-
eties that oversee the accuracy, safety, and quality of RT treatments. In March 2014,
these societies started the Radiation Oncology Incident Learning System (RO-ILS)
to enable documentation and analyses of incident reports in the radiation oncology
domain.
In the wake of RO-ILS, the Veterans Health Administration (VHA) has deployed
the Radiotherapy Incident Reporting and Analysis System (RIRAS). The system is
being used by the 40 VHA radiation therapy centers as well as the Virginia Common-
wealth University (VCU) Health center. RIRAS is a web-based Incident Learning
System (ILS) developed by TSG Innovations Inc. and is accessible via the intranet,
where any member within the department can submit incident/good catch reports.
The taxonomy, data dictionary, and radiotherapy process of care incorporated in the
design of RIRAS are based on the AAPM report on “Error Reporting” [52]. Further-
more, RIRAS is fully compliant with the Patient Safety and Quality Improvement
Final Rule [53]. RIRAS is built to report all types of workflow events, that includes
even minor errors in documentation and processes; such errors may decrease the
efficiency of treatments and cause delays besides having other downstream effects.
Figure 29 shows the typical schematic representation of the RIRAS system. All
events reported are reviewed by the ILS committee on a call or face to face interac-
tion; typically such ILS team comprises of medical physicists, dosimetrists, therapists,
nurses and physicians. The ILS team completes the analysis form section where event
summary titles, error type, causes based on a standard dictionary and safety barriers
or quality control measures affecting the event are entered. The event is reported to
the chief of the appropriate clinical group if the severity is determined to be high or
the ILS team determines that further review is necessary. Otherwise, the ILS commit-
tee reviews and codes the events by consensus at their weekly review meeting. Severe
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incidents require immediate action and root cause analysis (RCA). Understanding
the cause of severe incidents helps in preparing an appropriate plan of action. Even
the less severe incidents are further analyzed and tracked to avoid similar events. An
appropriate action plan and feedback is sent to the incident reporter and professional
group so that policy and process can be improved.
Natural language processing (NLP) is a popular technique for analyzing large
quantities of clinical texts, notably in medical specialties such as radiation oncology
and radiology [54, 55]). According to Meystre and Pons [55], the five major cate-
gories of application of NLP in radiation oncology are (1) diagnostic surveillance, (2)
cohort building for epidemiological studies, (3) query-based case retrieval, (4) quality
assessment of radiologic practice, and (5) clinical support services. In this chapter, we
introduce a sixth category for the application of NLP in radiation oncology: analysis
of radiotherapy incident reports. Specifically, we present the use of NLP to automate
the prediction of severity from the incident description. As shown in Figure 29, the
bottleneck step in the RIRAS system is triaging. We propose a machine learning
method to automate the triage process which can thereby reduce the manual efforts
needed by the subject matter expert (SME) to determine the severity; providing an
initial prediction of low and high severity with confidence also helps to augment the
incident analysis process.
The rest of the chapter is structured as follows. In Section 5.3, we present the
methods used and details of the dataset. Section 5.4 describes the results and in
Section 5.5, we present the discussion and conclusion. In the final section, we present
the limitations in our approach that can motivate future work.
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Fig 29: Schematic Representation of Radiation Oncology - Incident Learning System
(RIRAS).
5.2 Background
Healthcare incident reports, including the radiotherapy incidents submitted into
the RIRAS software, are similar to the safety reports of various industrial environ-
ments in that their narratives are reported in an unstructured free-text format. Free
text, while convenient for the reporter, presents a challenge for data aggregation and
requires suitably-qualified personnel to read and analyze. However, due to the lack
of dedicated incident-analysis personnel, minor incident reports in healthcare often
accumulate, as resources are used to deal with front-line issues that are typically
considered more urgent.
To the best of our knowledge, there is no work reported in the field of radiotherapy
to identify the severity of the incidents reported using incident description. However
there have been well reported research in other industries such as aviation, and nuclear
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[56, 57, 58, 59, 60] to classify the incidents reported in the respective fields. In
healthcare there has been successful work done in classifying the verbal autopsies
[61]. A team in Canada has done a study on identifying the incident types from
Canadian medication incident report [62]. Another team in Australia performed
more extensive study predicting the two types of patient safety incidents: incorrect
patient identification and inadequate clinical handover [63]. Hence, there is an urgent
need for creating an actionable learning-based incident reporting system in healthcare
[64].
5.3 Methods and Materials
5.3.1 Dataset
RIRAS is a web-based ILS deployed on the VHA radiation oncology centers in-
tranet and VCU intranet in early 2014. It was designed to collect good catch data
and adverse events, besides analyzing their causes and contributing factors, and fi-
nally, to prevent possible occurrences in the future. This system provided a platform
to report the adverse events across 40 VHA radiotherapy treatment centers. We col-
lected data from both sources, which consisted of incidents that were triaged into four
levels of severity, namely, A through D, where A is most severe, and D is least. From
here on, the dataset collected from VHA centers and VCU radiotherapy center will
be referred to as VHA data and VCU data, respectively. Table 17 shows the sam-
ple examples of incident descriptions reported and their respective severities assigned.
VHA Dataset: The VHA clinical reporters entered incidents into RIRAS since
2014. For the time period between 2005 and 2014, the incident reports were collected
for only high severity (level: A) incidents. These reports were collected by mostly
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emailing the VHA’s National Health Physics Program office who logged the reports
in excel spreadsheets. These reports (46 reports) were entered into RIRAS in 2015.
For the purposes of this analysis we used the data collected till 2017. A total of
530 incidents were reported across the VHA centers at the time when this data was
collected, in which 345 incidents were analyzed by the subject matter experts and the
incident analysis reports were assigned severities. The incidents distributed based
on the severity in VHA dataset is as shown in Figure 30a, where the incidents are
distributed as A (62), B (52), C (162), and D (67). A total of 185 incidents were not
analyzed and hence were missing the severities; such non-analyzed incidents cannot
be used in our classification task.
VCU Dataset: The incidents collected at VCU were between 2014 to 2019.
A total of of 540 incidents were reported, among which 7 were not analyzed by the
subject matter experts. The incidents were distributed based on their severity as
shown in Figure 30d, where the incidents were distributed as A (9), B (40), C (165),
and D (318). A total of 7 incidents were missing severities.
5.3.2 Incident Severity Types
The AAPM (professional society of Medical Physicist in the US) formed a work-
ing group on Prevention of Errors in Radiation Oncology where a panel of experts
developed consensus recommendations considering five key areas: data elements, def-
initions, severity scales, process maps, and causality taxonomy [52]. RIRAS was
implemented following these recommendations. Following are the important termi-
nologies related to ILS:
• Incident: refers to events that are unintended or unexpected in the realm of
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Incident Description Severity
The patient on the EMR screen was not the patient
called for treatment. During set up the radiation ther-
apist noticed that the patient on the table is not the
patient selected on EMR. Introduced new policy of dou-
ble checking the patient ID by therapists.
High (A or B)
Spinal cord and Brainstem max doses were incorrectly
recorded in dose summary spreadsheet and in paper
chart and Aria printouts. Aria dose recording paper
chart and Aria PDF were corrected.
Low (C or D)
Table 17: Examples of Incident description and respective Severity assigned by Sub-
ject Matter Experts.
standard clinical operations. Such events may cause adverse effects on equip-
ment, healthcare providers or patients.
• Near Miss or Good Catch: refers to unplanned events that could potentially
cause a damage, illness or injury, but did not actually do so. However, such near
misses were only averted due to good fortune. Such events are mostly labeled
by ”human error”, while faulty systems or processes may exaggerate the harm,
and needs to be studied better. Other terms used for such are ”close call”, and
for moving objects, ”near collision”.
• Unsafe Condition: refers to hazardous work environments, circumstances, or
physical conditions that increase the probability of an incident.




Fig 30: Dataset Distributions: (a) Severity Distribution in VHA dataset. (b) Severity
Distribution in VCU dataset. (c) Word Distribution in VHA dataset. (d) Word
Distribution in VCU dataset.
facilities treating over 12,000 patients annually within the system, and an additional
14,000 outside of the system. As the rate of errors has been estimated to occur as
frequently as 1 per 600 patients [65], the utilization of ILS can provide a means of
gathering and analyzing incident data so that patient safety and workflow process
improvements can be implemented and the effects of such changes tracked over time.
For multi-institutional programs such as the NROP, aggregating incident reports
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from all facilities into a single database increases the effectiveness of incident learning
and allows for the assessment of systematic errors and trends as well as national
standardization of policies and procedures. Based on the recommendation of AAPM,
NROP defined the reasoning behind the severity categorization and explained what
constitutes of low to high severity. Reports were subsequently categorized based on
four levels of severity: A through D. Explanations for these incident severity categories
are shown below:
• Level A: It is a significant event or near miss with a potential for a medical
event or serious patient injury, as well as a repeat of a Level B event. The
problem has an urgent need for correction and may impact multiple patients
or Radiation Oncology processes. Level A incidents require a full Root Cause
Analysis. The Lead Responder for a level A incident will typically be a medical
physicist. Very few (< 2%) incidents should fall into this category.
Example: A patient is treated at the wrong site. The Lead Responder would
be a medical physicist appointed by the Director of Clinical Physics.
• Level B: It is a significant event or near miss that did or could result in a dose
deviation > 5%, a significantly larger than intended dose outside the treatment
field, a treatment delay of greater than one day, or a similar scenario that
is neither a Medical Event nor poses a risk of serious patient/staff injury. The
problem should be confined to a single process step and could likely be promptly
addressed with an Apparent Cause Analysis. The Lead Responder for a level
B incident will either be a medical physicist or a department lead. Few (< 5%)
incidents will fall into this category.
Example: A case is planned and treated for five fractions (out of 20) with
an improperly expanded contour that is 5 mm larger than intended by the
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physician. The Lead Responder would be the Director of Dosimetry.
• Level C: A minor incident, near miss, or condition that warrants an appropriate
response from a department lead, who is typically the Lead Responder. The
level of the response will be up to the department lead, but the response must
be reported back to the Quality Assurance (QA) committee. Many incidents
will fall into this category.
Example: A case is planned and prepared for treatment assuming 5 mm bo-
lus. The physician opts not to use the bolus, and only the monitor units are
not recalculated before treatment approval. The Lead Responder could be the
Director of Clinical Physics.
• Level D: A very minor incident, near miss, or condition that warrants awareness
by the department lead. The level of the response will be up to the department
lead, and there is no mandate for them to report back to the QA committee.
The incident will be logged within RIRAS for trend tracking purposes.
Example: A field is mislabeled in a plan. The Director of Dosimetry is informed.
5.3.3 Model Selection
In this section, we describe the model selection techniques using traditional ma-
chine learning and deep learning approaches with model fine tuning and transfer
learning.
5.3.4 Traditional Machine Learning
We first pre-processed the textual data from the incident reports. Next, we iden-
tified the features from the text to build the corresponding feature vectors necessary
for any supervised machine learning model. The next step was to select the appro-
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priate machine learning algorithm for which we tested different types of algorithms
to predict the severity of the incidents.
Since machine learning algorithms require numerical data, we next converted the
textual data into numerical features. This involves the following major steps [30]: 1)
tokenization, 2) feature set generation, and 3) vectorizing the features with different
feature weight calculation techniques. To this end, we applied the following steps in
developing the proposed traditional machine learning pipeline (as shown in Figure
31).
Fig 31: Triage Process: Pictorial representation of the traditional machine learning
severity classification pipeline.
5.3.4.1 Data Splits:
As before we built a model by splitting the data into three sets: the training set,
validation set and test set. Using the separate data for evaluation not seen during
training lets us test if the trained model is not over trained. Once the final model is
prepared, the test dataset is used to test the model with unseen data (not seen during
training and not used as validation).
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5.3.4.2 Data Preprocessing
All incident descriptions were first processed using NLTK (python library for
text processing) [66]. The following procedures were applied:
• Data Cleaning: Removing the unnecessary parts of text. In our dataset, we
removed the characters “&amp;quot”, “&amp;&amp;”, which were added to
the text when collecting the data from XML files.
• Tokenization: It is the process of splitting the long string of text (sentences)
into tokens (words). These tokens are used as features. We used NGram tok-
enization to produce uni-gram, bi-grams, and tri-grams [67]. Uni-grams are also
known as bag-of-words representing individual terms that occur in a document
(e.g., “surgery”, “prostate”, “dosimetry”). bi-grams and tri-grams represent
the consecutively occurring two or three terms in a document (e.g., patient
scheduled, patient rescanned, patient planned radiation therapy), which help
capture the semantics of text; one such example is negation (e.g., no pain).
• Text Normalization: It is the process of converting terms occurring in text
into one form. We used lower case normalization to ensure that all the words
occurring in different forms are represented as one (e.g. Patient, PATIENT,
patient, and pAtient are converted to “patient”) [68].
• Stopword Removal: It is the process of identifying and removing more fre-
quently occurring words from the text. We considered removing commonly
occurring English language words (e.g. a, the, it, what, why, she, etc.), which
hold no classification value [67]. We used general English language stop words
provided in the NLTK Package. This technique is commonly used in informa-
tion retrieval and NLP document classification implementations [68].
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• Term frequency filtering : It is the process of identifying the infrequently
appearing words in the corpus [69], which helps with reducing the feature vector
size. We have used a minimum term frequency of 5 as cutoff.
• Feature Weighting Techniques: We used three types of feature weighting
methods as shown below. Term presence (tp), Term Frequency (tf), and Term
Frequency-Inverse Document Frequency (tf-idf). We have explained each of
these weighting techniques in Section 3.3.4
• Vectorization – It involves using the above steps to extract features and
weights to generate uniform vector representations of each report. Each feature
weighting technique (shown above) was used to create three types of feature
vectors. One such feature weighting technique is tf-idf ; tf-idf assigns the weight
to the term based on its frequency in a document, and its appearance in all
documents in the corpus. The assigned weight indicates the relevancy of that
term to the document when classifying the documents into different classes [68,
70, 71]. The higher value of the term indicates its higher importance. The term
frequencies are normalized so that longer documents do not skew the results
[72].
5.3.4.3 Classification Algorithms
We next tested the classification algorithms explained in Section 2.3 to select the
best algorithm for the traditional machine learning pipeline.
5.3.4.4 Evaluation Metrics
To evaluate our model we considered macro-averaged precision, recall, and F1-
Score that can better capture how well a classifier can identify cases that it does not
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see often as explained before. Results are also presented using a confusion matrix
which shows the number of correct and incorrect predictions as summarized with
prediction counts between each class. It provides insight not only into the errors
being made by the classifier but more importantly, the types of errors that are being
made.
5.3.4.5 Initial Model Selection
The extracted incident reports were used to train machine learning classifiers
with Python’s scikit-learn (version 0.21.3) [39]. The labeled incident report corpus
was stratified as 80:20 as training and test split. A total of 276 (80%) incident reports
were used for model training and 69 (20%) for model testing to characterize the model
performance.
In our initial work, to test the viability of predicting all four severities, we built
four different models by combining severities as below [7]:
• Model-1: We considered incidents with severities A and C.
• Model-2: We combined A&B as high and C&D as low severities.
• Model-3: We considered only B and D severity.
• Model-4: All 4 severities, A, B, C, and D are considered as separate.
These models provide insight into our methods’ ability to find patterns when
incidents with different severities are considered. We built above mentioned four
models with SVM-linear classification algorithms, and NGram features with tf-idf
feature weights. Table 18 shows the results of these four models. We observed that
Model-1 and Model-3 achieved an F1-Score of 0.87 and 0.78 respectively; we can infer
that incidents A & C (Model-1) and B & D (Model-3) have better patterns to classify
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incidents. The poor performance of Model-4 indicates that there is a lot of similarities
between the A & B and C & D severities in the confusion matrix. Model-2 achieves
the F1-Score of 0.81. It is clear from the results that predicting all the four categories
is difficult based on our current datasets. However, categorizing incidents into high
(A&B) and low (C&D) severity (Model-2) is viable.
Models Severities Precision Recall F1-Score
Model-1 A and C 0.86 0.87 0.87
Model-2 A&B and C&D 0.83 0.80 0.81
Model-3 B and D 0.80 0.77 0.78
Model-4 A, B, C, and D 0.53 0.56 0.53
Table 18: Results from the severity categorization model for different combinations
of severities. Results reported are macro-averaged precision, recall and F1-Score for
SVM with linear kernel model.
Hence, we used Model-2 for building the automated triage system. To select the
best classification algorithm to build the final model, we applied the above explained
steps to build the severity prediction model. Figure 31 shows the pictorial represen-
tation of the classification pipeline. Five different classification algorithms were used:
k -Nearest Neighbors (KNN) [18], SVM-Linear [15], SVM-RBF [16], Random Forests
[20], and Logistic Regression [38] with feature extraction and weighting methods.
Standard macro-averaged precision, recall, and F1-Score are used as evaluation met-
rics for discrimination on the training and test sets. Table 19 and 20 shows the initial
model selection results for VHA and VCU datasets. We observed that SVM with
linear kernel consistently performed well with all feature vector generation methods.
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In all combinations of algorithms and features, SVM with linear kernel algorithm and
tf-idf features performed the best with an F1-Score of 0.808. With this observation,
we chose the tf-idf and SVM-linear to build our final model.
Dataset Features Algorithm Precision Recall F1-Score
Weights
SVM RBF 0.809 0.519 0.418
SVM Linear 0.792 0.698 0.705
tp Random Forest 0.856 0.685 0.686
Logistic Regression 0.792 0.698 0.705
KNeighbors 0.304 0.500 0.378
SVM RBF 0.797 0.655 0.649
SVM Linear 0.815 0.735 0.747
VHA tf Random Forest 0.837 0.729 0.740
Logistic Regression 0.815 0.735 0.747
KNeighbors 0.813 0.537 0.454
SVM RBF 0.720 0.562 0.512
SVM Linear 0.835 0.798 0.808
tf-idf Random Forest 0.818 0.692 0.696
Logistic Regression 0.759 0.599 0.571
KNeighbors 0.680 0.664 0.668
Table 19: Model-2 selection results for severity categorization for VHA dataset. Re-
sults reported are macro-averaged.
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Dataset Features Algorithm Precision Recall F1-Score
Weights
SVM RBF 0.458 0.500 0.478
SVM Linear 0.458 0.500 0.478
tp Random Forest 0.458 0.500 0.478
Logistic Regression 0.458 0.500 0.478
KNeighbors 0.458 0.500 0.478
SVM RBF 0.458 0.500 0.478
SVM Linear 0.460 0.500 0.475
VCU tf Random Forest 0.458 0.478 0.478
Logistic Regression 0.460 0.490 0.473
KNeighbors 0.458 0.500 0.478
SVM RBF 0.458 0.500 0.478
SVM Linear 0.460 0.495 0.475
tf-idf Random Forest 0.458 0.500 0.478
Logistic Regression 0.458 0.500 0.478
KNeighbors 0.457 0.490 0.473
Table 20: Model-2 selection results for severity categorization for VCU dataset. Re-
sults reported are macro-averaged.
5.3.5 Traditional Machine Learning Vs. Transfer Learning:
Traditional machine learning refers to training a model on a particular task (say,
text classification) from one domain and expecting it to perform well on unseen data
from the same domain. Whereas, transfer learning refers to the use of a model
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that has been trained to solve one task (e.g., language modeling: predict next word
in a sentence) as the basis to solve some other or somewhat similar problem (text
classification) [73]. It also refers to the training of a model with a large-scale dataset
and next using this pre-trained model for the same task with different dataset and
labels. The computer vision domain popularized transfer learning with the ImageNet
dataset [74].
Fig 32: (A) Traditional machine learning system (B) Transfer Learning system.
Figure 32 (A) shows the traditional machine learning setup. This method is
isolated and performs single-task learning. It is not possible to use the knowledge
from one task to learn the new task. Traditional machine learning also needs a lot
of data to learn the given task. Whereas, Figure 32 (B) shows the transfer learning
setup. This setup utilizes the knowledge learned from one task to learn a new task;
because of the knowledge transfer, it requires less data and computation time to learn
a new task.
5.3.6 Transfer Learning
Transfer learning is the process of training a model on a large-scale dataset
and then using the pre-trained model to conduct learning for another downstream
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task. One such simple transfer learning technique is to use the word2vec embeddings,
which uses a single layer of weights from the trained model. However, full neural
networks in practice contain many layers, and using transfer learning for a single
layer is only scratching the surface of what is possible. From the immediate past, one
such technique that fine-tunes the full network for transfer learning on textual data
is the universal language model fine-tuning (ULMFiT) [75].
Universal Language Modeling and Fine Tuning
The ULMFiT is one of the revolutionary algorithms in the field of NLP for
knowledge transfer used for text classification. It uses all the layers of a neural
network for transfer learning. Figure 33 shows the high-level pictorial representation
of ULMFiT.
Fig 33: Pictorial representation of high level Universal Language Model Fine-tuning
(ULMFiT) approach used for incident triage.
The ULMFiT has three main steps.
1. General Domain Language Modeling: In the first step, an unsupervised lan-
guage model is trained on a large corpus to generate a general-domain language
model. For this, a pre-trained general-domain English language model was
used [75], which is trained with language model ASGD Weight-Dropped Long
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Short-Term Memory (AWD-LSTM) on Wikitext-103 [76].
2. Target Task Language Model Fine Tuning: In the second step, the general
domain language model is fine-tuned with the domain/target specific dataset.
A pre-trained general-domain language model allows the target task language
model to converge faster and results in a robust language model even for small
target datasets. A pre-training provides a robust representation for uncommon
words in the target training dataset.
3. Target Classifier Fine Tuning: In the third and final step, it adds two additional
linear blocks to the pre-trained language model. The first linear layer takes the
pooled last layer of the language model as input on which it applies ReLU
activation. The last layer is a fully connected layer having softmax activation
that provides the target classes’ prediction probability.
5.4 Results
In this research, our goal was to augment the triage process in RIRAS by predict-
ing the severity of the incident using the textual description of the incidents reported.
We used two different approaches to predict the severity of the reported incidents:
a traditional ML and transfer learning approach with the more advanced algorithm
called ULMFiT. Below we describe the results from each of these approaches.
Traditional ML Results
From the initial model selection results, we observed that SVM-linear performed
best in comparison with others. Hence, we used the SVM-linear to build the final
model. We built separate models for VHA and VCU datasets. Table 21 shows the
traditional ML results. We compared the results with the majority label baseline
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(MLB Baseline) model. In the MLB baseline, all the predictions are done as a label
that occurs the majority of the time. The metrics are calculated based on the majority
label. In a balanced binary classification model, the random probability of predicting
a correct class is 50%, but both the datasets used in this work are imbalanced. Hence,
we compared the results with the Random and MLB baseline. The VHA dataset
model achieved 0.80, 0.77, and 0.78 of precision, recall, and F1-Score, respectively.
When compared to the MLB baseline, it achieved much better results. Whereas
for VCU, we noticed that SVM-Linear results are the same as the MLB baseline,
indicating that the model was not able to learn the classification patterns from the
training data. Figure 34 shows the confusion matrix of traditional ML results for
both VHA and VCU. We noticed that for the VCU dataset, the ML model assigned
the Low severity (majority label in the training set) to all test set instances.
Models DataSource Precision Recall F1-Score
Random − 0.50 0.50 0.50
MLB Baseline VHA 0.33 0.50 0.40
VCU 0.458 0.500 0.478
SVM-linear VHA 0.80 0.77 0.78
VCU 0.458 0.500 0.478
Table 21: Traditional Machine Learning Results for Model-2. Reported results are
macro averaged precision, recall, and F1-Score for SVM with linear model. MLB:
majority label baseline.
106
Fig 34: Traditional ML Results Confusion Matrix. Left confusion matrix is for VHA
test set and right is for VCU test set. Diagonal indicates the correctly predicted class
count.
Transfer Learning Results
Table 22 shows the results for different models built with ULMFiT. As explained
in Section 5.3.6, transfer learning is a way to utilize the knowledge learned from one
task into another task. In this research, we used ULMFiT to build the transfer learn-
ing based approach to predict the severity of incident reports in radiation oncology.
ULMFiT involves building the language model (LM) and use it in the classification
model.
In order to test the effects of data source on the models’ ability to predict the
severity of the incident reported using the descriptions, we built three different LM
models based on the data source: VHA, VCU, VHA VCU; the VHA VCU dataset
combines both the VHA and VCU datasets. Next, we trained the separate classifica-
tion models with VHA and VCU datasets by taking knowledge from the LM models.
This provided us with (3 X LM model) X (2 X Classifiers) = 6 pipelines to test for
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LM Train Test Precision Recall F1-Score Support
VHA VHA VHA 0.77 0.78 0.78 69
VHA VCU VHA 0.68 0.61 0.61 69
VCU VHA VHA 0.80 0.83 0.81 69
VCU VCU VHA 0.33 0.49 0.39 69
VHA VCU VHA VHA 0.76 0.79 0.75 69
VHA VCU VCU VHA 0.54 0.51 0.46 69
VHA VHA VCU 0.56 0.68 0.48 106
VHA VCU VCU 0.67 0.69 0.68 106
VCU VHA VCU 0.55 0.64 0.53 106
VCU VCU VCU 0.46 0.49 0.47 106
VHA VCU VHA VCU 0.55 0.61 0.54 106
VHA VCU VCU VCU 0.59 0.54 0.55 106
Table 22: Transfer Learning Results for Model-2. First six rows for VHA test set
models and last six rows are for VCU test set. Results reported are macro-averaged.
Support indicates the total number of samples in test sets. LM: Language Model.
each data source, and a total of 12 models for VHA and VCU. Table 22 shows the
transfer learning results. The results reported are macro-averaged precision, recall,
and F1-Score.
We observed that transfer learning results are comparably better than traditional
ML learning results. For the VHA test set, we noticed that the pipeline with VCU
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Fig 35: Transfer Learning Results: Confusion Matrix for each model in test dataset.
Title in each confusion matrix indicates the respective model. Top two rows (six
models) is for VHA test set and bottom two rows (six models) for VCU test set.
Diagonal indicates the correctly predicted class count.
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LM model and classification model trained with VHA achieved the best results. LM
models trained separately with VHA, VCU, and VHA VCU performed similarly for
the VHA test set. It is clear from the results that the classification model needs to
be trained with VHA data to predict the VHA test set. Transfer learning models
performed well for the VCU dataset with precision 0.67, recall 0.69, and F1-Score of
0.68 compared to the traditional ML model. Figure 34 shows the confusion matrices
for all the models. The model with LM trained on VHA data and classifier trained
on VCU data performed better on the VCU test set.
5.5 Discussion
In this chapter, we presented an approach to predict the severity of the radiation
oncology incidents. The purpose of this work is not to replace the manual triage
process, but rather, augment it by predicting the severity of the incident with reported
description and provide the recommendation to the subject matter experts on the
likelihood of an incident being of low or high severity. To do that, we used NLP
techniques and ML algorithms to build the automated triage pipeline. We used
traditional ML and transfer learning approaches.
The datasets used in this work come from two different sources; they are similar,
yet have different characteristics. We noticed that the distribution of incidents based
on the severity type is different in VHA and VCU datasets; there are fewer High
severity incidents in the VCU dataset compared to the VHA dataset even though
the total number of incidents in VCU are higher than VHA. We noticed that the
descriptions of the incidents reported in the VHA dataset are longer on average com-
pared to the incident descriptions reported in the VCU dataset. The length of the
incidents also correlates with the severity of the incidents. The High severity (A & B)
incidents, on average, have long descriptions compared to the Low severity (C & D)
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incidents. It does not mean that the length of the description of the incident indicates
the severity of the incidents. However, we believe it may be because the incident re-
porters tend to describe incidents in detail if they deem the incident is severe. The
difference in length of descriptions may be due to the institution type and practice at
those institutes. VHA incidents are coming from 40 VHA treatment centers, whereas
VCU is a single institute. NLP makes use of the words in the description to find the
patterns of the specific severity. Hence, a well-explained description is always better
than a short one. Talking to SMEs, we have learned that some times just incident
description provided is not enough to infer the severity; they always reach out to inci-
dent reporters for more information before analyzing the incident and assign severity.
Thus, we believe that there is a need and opportunity to build guidelines on reporting
practices. All the staff who use the RIRAS system to report incidents needs to be
aware of guidelines and follow the instructions while reporting an incident.
Comparison with previous work
While ML and NLP based methods have been widely used to analyze incident
reports from other domains, such as aviation [77], they have only been scarcely used
in the healthcare domain before [63]. Straightforward comparison of our work with
others is not possible because of the following two reasons. First, there has been no
prior work related to the radiation oncology incident severity prediction using ML and
NLP. Second, related work in healthcare incident analysis is more focused on other
types of incident reports, where such incidents were recorded as free text. For exam-
ple, Wong and Akiyama [62] analyzed 227 medication incident reports using a logistic
regression based classifier to categorize the incident types based on adverse drug ef-
fects. Similarly, Wang et al. [78] used an integrated ML and NLP based pipeline to
categorize incident reports related to patient safety; however, their method performed
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poorly in properly classifying the severity levels. Finally, another related work in the
healthcare domain considered verbal autopsies for text-based classification [61] with
good accuracy; such autopsies bear some resemblance to incidence reports. However,
none of these works are directly comparable to our proposed method which considers
incident reports from the radiation oncology domain for automatic classification of
severity levels and hence precludes any direct comparison with prior work.
Limitations
The work presented in this chapter for automatic incident triage in radiation
oncology - incident learning system has the following limitations.
First, the method proposed was only able to predict the severity into only High
or Low categories, not four as required in the incident learning system.
Second, with this approach, we are unable to type incident, which is significant
for making an effective change in the ILS system.
5.6 Conclusion
Incident reports in the radiation oncology domain provide very useful informa-
tion to analysts and subject matter experts to decide on the right course of action
for incidents. With the current trends in digitization of medical data (such as, in-
cident reports) and automation of operations and logistics (such as our proposed
automated incident triage and prioritization module), artificial intelligence related
methods have become a necessity. In this chapter, we presented a deep learning
based ULMFiT model that can effectively identify the incidents based on the initial
report and narrative. We demonstrated that this transfer learning based approach
outperforms standard supervised machine learning based approaches for classifying
narratives. Our work provides encouraging results towards the end goal of a fully
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automated incident triage and prioritization system in the future. Additional data
from the national safety registry RO-ILS should help to improve the accuracy of our
proposed model and provide human-level fidelity and performance. Our models can
also work on retrospective data on incident reports to automatically classify the in-
cident severity and provide rapid summarization of past events for subsequent data
driven research studies in the future.
Contribution summary: In this chapter we focused on the safety aspects of ra-
diation oncology. We specifically looked at the triage process in incident learning
system. Specific contributions of this chapter are as follows.
1. We present an approach to automatically identify the severity of the radiation
oncology incidents using the textual incident description.
2. We demonstrate that identifying the severity is a challenging problem when it
comes to classifying the incidents into the four possible categories using just the
incident description. However, merging severity types into two categories (High
and Low severities) results in much better classification results considering the
incident report data from multiple VHA radiation oncology centers as well as
the VCU medical center datasets.
3. We next demonstrated that transfer learning does help in the severity prediction
process specifically considering multi-institution data that may each follow a
different protocol for recording the incident reports.
4. We show that incident reports are correlated with institutional practices and
there is a need for standardized incident reporting guidelines to reduce the
subjective incident analysis practices.
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CHAPTER 6
ANALYSIS OF TREATMENT SELECTION PRACTICES FOR
INTERMEDIATE OR HIGH RISK PROSTATE CANCER
Fig 36: Thesis contribution, Chapter 6 contributions are highlighted.
6.1 Introduction
Prostate cancer (PCa) is the most commonly diagnosed type of cancer after
breast and lung cancer. In 2018 alone, over 160,000 new prostate cancer cases and
over 29,000 prostate cancer-related deaths were estimated in the United States [79].
PCa is also one of the most heterogeneous type of cancer specifically with respect to
intermediate or high-risk PCa [80]. The non-invasive prostate-specific antigen (PSA)
test that has led to an increase in early detection of PCa leading to more localized
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PCa diagnosis in recent years [81].
The National Comprehensive Cancer Network (NCCN) provides clinical prac-
tice guidelines that are created by physicians to determine the best way of treating
PCa patients (besides other types of cancers), depending on their diagnosis, disease
stage, age and other factors. PCa is also treated with monotherapy or polytherapy.
Physicians select the treatment modality based on four major criteria - age, race,
life expectancy, and NCCN Risk. Factors such as patient preferences, survivorship
goals along with tumor biology also play a crucial role in optimizing the treatment
modality.
A major consideration during the treatment options for PCa is to check whether
the cancer is contained within the prostate gland (localized), or has spread outside the
prostate (locally advanced) or has spread to other parts of the body (metastasized).
Radical prostatectomy (RP), external beam radiotherapy (EBRT) and brachyther-
apy (BT) are the common primary treatment options for localized PCa. Hormonal
therapeutics such as androgen deprivation therapy (ADT) is also used as neoadju-
vant/adjuvant therapy. However, ADT as monotherapy is not recommended for inter-
mediate and high-risk cancer patients by NCCN. Ideally, a treatment option recom-
mendation would be based on the randomized controlled trials (RCT) that compare
efficacy and morbidity of alternative treatment methods. There are no randomized
trials showing that one treatment is better than the other for the above-mentioned
treatment options. Hence, physicians use their personal experience and expertise to
predict the outcome of these treatment methods. Physicians also tend to have diffi-
culty weighing the relative importance of each of these factors and inherently possess
biases when predicting the treatment outcomes.
Based on the aforementioned considerations, determining an optimal treatment
plan for the patient can be a challenging task for the physician. In order to assist
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the physicians with more accurate prognosis, subsequent treatment outcome predic-
tion, and to make informed decisions, numerous predictive tools have been devel-
oped [82]. These include probabilistic models, lookup and propensity scoring tables,
risk-stratification tools, classification, and regression tree analysis, nomograms, and
artificial neural networks[83, 84, 85, 86, 87, 88, 89, 90, 91, 92]. However, to the best
of our knowledge, no models have been reported that can identify why a prescribed
(or administered) treatment plan do not adhere to NCCN guidelines.
The predictive models for treatment plan (or outcome) prediction have a ma-
jor disadvantage. Such models do not consider the impact of non-clinical factors
associated with the treatment center. The factors associated with the treatment cen-
ter have shown to play a determining role in the physicians’ treatment prescription
practices. Non-clinical factors can be patient-related, physician-related or practice-
related. These factors include patient’s preference/availability, patients’ adherence,
physician’s availability, cost, geographical proximity, treatment centers’ equipment
condition/availability, treatment centers’ cultural aspects, type of practice (private
vs. public), availability of health resources, etc.[93, 94, 95, 96]. However, there have
not been many studies which have investigated the extent of the contribution of these
factors in the treatment selection process itself. Thus the motivation of this study is
two-fold:
1. To use both clinical and non-clinical features for localized and locally advanced
PCa patients from multiple Veterans Health Administration (VHA) centers and
use machine learning methods to predict the treatment prescribed; such meth-
ods provide a statistical approach for calculating the weight (impact) of these
clinical/non-clinical features from an empirical and retrospective point-of-view.
2. To perform quality assurance assessments across the different centers and verify
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if the prescribed treatments were in concordance with NCCN guidelines.
This study presents a comparative analysis of treatment prescription consistency
across multiple VHA centers.
6.2 Materials and Methods
6.2.1 Dataset
The VHA has 40 centers treating cancer patients with radiation therapy (RT)
across the US. But for this study, a maximum of 20 patients from 34 VHA RT centers
are selected based on the whose treatment was completed below criteria.
• Patients should have been treated between 2010 to 2017.
• Patients must have been treated for intermediate or high-risk PCa.
• Patients must not have previous malignancy, M1 disease, or lymph node in-
volvement.
A total of 552 patients from the 34 centers were selected. Subject matter expert
(radiation oncology nurse) gone through all health records to manually extract the
related clinical information. Hence, we consider this dataset as a gold dataset. Table
24 show the dataset details.
The dataset was split 80 : 20 ratio into training and test sets. One hot encoding
technique was used to binarize the categorical features, this technique simply creates
additional features based on the number of unique values in the categorical feature.
Every unique value in the category will be added as a feature. Continuous features
were scaled to a min-max scale (for normalization). We used random forest algorithm
for building predictive models. Models are evaluated with macro-average precision,
recall, and F1-Score.
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6.2.2 Definitions of Variables
Definitions of variables used in our study are as follows.
Clinical variables: We considered pre-treatment PSA count, Gleason score
(GS) [primary grade, secondary grade], Gleason Grade, Tumor staging [TNM-stage],
NCCN risk group, performance status, and quality of life (QoL) measures. The values
for these clinical variables were manually extracted from the consult notes. :
Non-Clinical Variable: We defined Center-ID as a non-clinical variable. It
designates a unique ID to identify the VA radiation treatment center.
ADT Duration: NCCN guidelines define ADT duration as short term (ST)
or long term (LT). ST duration is 4-6 months, and LT duration is 2-3 years. We
further differentiated ADT duration based on intended and administered duration.
The intended duration signifies whether it was mentioned in consult notes during
treatment planning, whereas ADT administered duration is calculated based on the
dates of ADT injection. Table 23 shows the ADT injection type and their effective
period in months depending on the dose. Table 25 shows the distribution of ADT
intended and administered duration. A third category of not otherwise specified
(NOS) was used to indicate cases where ADT duration was not mentioned in consult
as a treatment plan.
Treatment Prescribed: During the consultation, the radiation oncologist dis-
cusses with the patient all possible treatment by explaining the side effects of each of
the treatment plan. The decision is taken with the patient, and this intended treat-
ment is recorded in consult notes. Hence, we call this treatment intended at the time
of consult as treatment prescribed.
Treatment Administered: At the end of the treatment, radiation oncologists
make a note of treatment details. We call this treatment as treatment administered.
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We have used two different terminologies because, for some patients, there is a change
in from intended to administration treatment. This change in treatment was mainly
observed in the ADT duration.
NCCN Concordance: We defined the treatment prescribed or administered is
concordant with NCCN guidelines if they were as per the NCCN guidelines [97].
ADT Injection Dose Effective Period
3.75 mg 1 month
7.50 mg 1 month
Leuprolide 22.50 mg 3 months
30.00 mg 4 month
45.00 mg 6 months
3.60 mg 1 month
Goserelin/Zoladex 10.80 mg 3 months
Table 23: ADT Injection Effective period based on the injection type and dose.
6.2.3 Model Selection
In this section we present the details of feature-set selection, predictive models,
machine learning algorithms, and model evaluation metrics.
We used machine learning algorithms as a statistical tool to find the association
between the treatments and clinical and non-clinical features. We used a supervised
machine learning algorithm called random forests (RF) [20], to find these associations.
The RF algorithm takes the features (clinical and non-clinical variables) and target
(treatments) to builds multiple decision trees and merges them together to get a
more accurate and stable prediction. It also provides the significance of features in
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Data Element Count Percentage
Total Patients 552 -
Centers 34 -
Gleason Score
Primary + Secondary 549 99.50
3 + 3 17 3.00
3 + 4 219 39.67
4 + 3 128 23.18
3 + 5 18 3.26
4 + 4 79 14.31
5 + 3 2 0.36
4 + 5 61 11.05
5 + 4 19 3.44
5 + 5 3 0.54
NOS + NOS 2 0.36
PSA 549 99.50
T Stage 549 99.50
T1a - T2a 457 82.79
T2b - T2c 64 11.59






Performance Status 523 94.75
Quality of Life 400 72.46







Table 24: Details of the clinical factors in the VHA ROPA dataset and their distri-
bution, NOS: Not Otherwise Specified.
classifying the targets. The significance of all features sums to 1, where higher the
significance of a feature stronger is its association with the target class, and lower
significance indicates the weaker or no association.
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NCCN Risk Treatment ADT Intended Administered Concordance
Duration with NCCN
ADT-BT NS 1 - No
LT - 1 Yes
BT 24 24 Yes
EBRT 115 115 Yes
Intermediate LT 8 15 No
EBRT-ADT NS 11 - No
ST 142 146 Yes
EBRT-ADT-BT ST 1 1 Yes
EBRT-BT 2 2 Yes
EBRT 17 17 No
EBRT-ADT-BT LT 9 4 Yes
ST 1 6 Yes
High LT 185 145 Yes
EBRT-ADT NS 18 - No
ST 12 70 No
Table 25: Treatment concordance with NCCN guidelines. ST :Short Term, LT: Long
Term, and NS: Not Specified.
6.2.3.1 Features and Labels
We created two feature sets using the clinical and non-clinical features to high-
light the contribution of non-clinical features. The feature sets (FS) are as below
1. FS-1: Clinical features only. ( PSA, Risk, Total GS, Primary GS, Secondary
GS, T Stage )
2. FS-2: Clinical and Non-clinical (Center-ID) features. (PSA, Risk, Total GS,
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Primary GS, Secondary GS, T Stage, Center-ID )
Above two feature sets used in two models with target labels as below:
1. Model-1 Labels: EBRT-ADT, ADT
2. Model-1 Labels: EBRT-ADT-ST, EBRT-ADT-LT
In below section we explain the two models we have built with combinations of
feature sets nd labels.
6.2.3.2 Statistical Models
VA-ROPA dataset has patients treated with six different treatment methods
(Table 24): BT, BT-ADT, EBRT, EBRT-ADT, EBRT-BT, and EBRT-BT-ADT.
Based on the available treatment plans, we built the following two models.
1. Model-1: Initial Treatment (EBRT-ADT vs EBRT ): This model predicts whether
the patients will be treated with EBRT and ADT (EBRT-ADT), or EBRT alone.
A total of 514 patients were treated with these two techniques, among which
382 patients were treated with EBRT-ADT, and 132 patients were treated with
EBRT alone.
2. Model-2: ADT Duration (EBRT-ADT-ST vs EBRT-ADT-LT): This model pre-
dicts whether the ADT duration is short term or long term. Model-2 is further
divided into 2A and 2B. Where 2A is EBRT with ADT intended duration and
2B is EBRT with ADT administered duration. 382 patients were treated with
EBRT and ADT. Table 25 shows the treatment with intended and administered
ADT duration.
These models use machine learning techniques to serve the dual purpose of (i) creating
a predictive model of initial treatment selection or ADT duration based on the clinical
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and non-clinical features and (ii) showing the statistical correlation of the individual
features in terms of impacting the treatment selection or ADT duration process.
6.3 Results
In this section, we present our results. Table 26 shows the Precision, Recall,
F1-Score for model-1 (EBRT-ADT vs EBRT). The goal in this model was to classify
patients with treatment intent being either EBRT or a combination of EBRT and
ADT (EBRT-ADT). Model 1 with FS-2 performed better in all metrics when com-
pared to FS-1. We observed that model-1 has F1-Score of 74% with FS-1 and 82%
with FS-2. These results clearly demonstrate the significance of non-clinical feature
(Center-ID) in improving the overall classification performance.
Model ADT F-Set Precision Recall F1-Score
Duration
Model 1 - FS-1 0.75 0.73 0.74
FS-2 0.82 0.82 0.82
Model 2A Intended FS-1 0.95 0.94 0.94
FS-2 0.92 0.92 0.92
Model 2B Administered FS-1 0.74 0.73 0.73
FS-2 0.72 0.71 0.71
Table 26: Macro-averaged Precision, Recall, F1-Score, for Model-1:(EBRT-ADT vs
EBRT), Model-2: (EBRT-ADT-ST vs EBRT-ADT-LT) 2A:ADT Intended Duration,
2B:ADT Administered Duration.
Table 26 also shows the results of model-2 (EBRT-ADT-ST vs EBRT-ADT-LT).
Interestingly, in this case, FS-1 and FS-2 perform quite similarly with 94% F1-Score
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FS Features Model 1 Model 2A Model 2B
ADT Intent ADT Administered
PSA 0.52 0.14 0.39
Risk 0.25 0.79 0.30
FS-1 Total GS 0.03 0.04 0.14
T stage 0.09 0.02 0.07
Primary GS 0.06 0.01 0.05
Secondary GS 0.05 0.01 0.05
PSA 0.23 0.08 0.24
Risk 0.28 0.79 0.27
Total GS 0.02 0.03 0.19
FS-2 T stage 0.07 0.02 0.05
Primary GS 0.13 0.02 0.04
Secondary GS 0.04 0.02 0.04
Center ID 0.29 0.06 0.17
Table 27: Feature importance in each model. Model 1:EBRT-ADT vs EBRT, Model
2A: ADT course intended, Model 2B: ADT course Administered. FS:Feature Set.
for models with ADT intent labels (with FS-1), while F1-Score is decreased when the
ADT administered labels were used. This may mean that some external factors (not
considered in our feature sets) play a role for causing the alteration from treatment
from the prescribed to administered. Also, non-clinical feature (Center-ID) found to
have no affect on predicting the ADT duration type as opposed to Model-1 (EBRT-
ADT vs EBRT). Based on these observations, we hypothesize that while centers do
play a role in determining whether to prescribe ADT or not, they do not impact the
124
actual ADT duration, in case it was administered; in other words, all centers follow
similar practice in administering ADT for localized intermediate or high-risk PCa
treatment.
We next evaluated the individual significance (i.e., contributions) of each of the
features from FS-1 and FS-2 in our models; the feature significance were generated
using the RF algorithm. Table 27 shows the feature importance of all features in all
models. For both FS-1 and FS-2, PSA and Risk consistently ranked as significant
features in all the models. Specifically, for FS-1, PSA was ranked as the top feature
for Models 1, 2B . For Model-2A (ADT duration intended), Risk was ranked as the
top feature. This suggests that decisions on ST or LT ADT duration depend primarily
on the Risk with PSA being a secondary feature of importance; these two features
are primarily responsible in deciding the ADT course at the initial treatment level;
however, decisions in altering the treatment intent (as captured in Model-2B with
treatment administered) are impacted by the PSA and Total Gleason score (which
is the third ranked feature in this model). For Model-1, PSA was ranked as the top
feature with Risk as the secondary feature and T stage as the third significant feature
suggesting that decisions on treating the patients with EBRT alone or a combination
of EBRT and ADT depend primarily on the Risk, PSA, and T stage values.
When we considered FS-2, PSA and Risk show similar significance. In this
case however, Center-ID plays a crucial role and shows up specifically as the top
ranked feature in Model-1 (EBRT-ADT vs EBRT); this reconfirms our earlier hy-
pothesis that nonclinical factors like the center play a significant role in determining
whether patients undergo ADT treatment or not. However, it’s significance is much
lower in Model-2A (EBRT-ADT-ST vs EBRT-ADT-LT) with ADT intended dura-
tion. Center-ID also shows up as the fourth ranked feature in Model-2B (EBRT-ADT-
ST vs EBRT-ADT-LT) for ADT duration administered; thus we can hypothesize that
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(A) (B)
Fig 37: Treatments in concordance with NCCN when all treatments are considered
at each center. Blue: treatments in concordance, Orange: not in concordance. (A):
Treatments prescribed at each center when ADT intent course is considered along
with all other treatments; (B): Treatments administered at each center when ADT
administered course is considered along with all other treatments.
nonclinical factors may have a role to play in altering the treatment intent.
We observed that treatment non-concordance with NCCN guidelines can be due
to the following two reasons:
• Firstly, overall treatment may not be in concordance with NCCN guidelines.
For example, high-risk cancer patients treated with EBRT alone are not in
concordance with NCCN. Figure 37 (A) & (B) shows the center wise all non-
concordant treatment counts based on ADT intended duration (i.e., prescribed
ADT) and ADT administered duration treatments respectively.
• Secondly, overall treatment is in concordance with NCCN however the treatment
guidelines may be partially not followed. For example, a high-risk cancer patient
is treated with EBRT and ADT, but ADT duration is for short-term instead
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(A) (B)
Fig 38: Patients treated with EBRT and ADT (Short Term or Long Term). Blue:
number of patients whose treatments are in concordance with NCCN, Orange: num-
ber of patients whose treatments are partially not in concordance with NCCN (A):
Treatments prescribed at each center when ADT intent course is considered (B):
Treatments administered at each center when ADT administered course is consid-
ered.
of long-term. Figure 38 (A) & (B) shows the partially non-concordant patient
count of each center when patients are treated with EBRT and ADT; the counts
are again based on the ADT intended and administered duration respectively.
6.4 Discussion
In this study, we present an exploratory analysis of localized or locally advanced
PCa patients from 34 different VHA treatment centers. We compared the treatments
prescribed against the NCCN guideline recommendations and observed that most of
the treatment plans (prescribed or administered) matched with the NCCN guidelines.
We built machine learning based models to predict the treatment plans for patients
and also the likelihood of NCCN concordance of their treatment plans. We observed
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that PSA and Risk were the top-ranked features in determining the treatment plans
for PCa patients.
Center-ID improved the performance of the model’s that predicts if the selected
treatment plan has ADT or not; however, it did not impact the models that predict
if the prescribed ADT duration was ST or LT. We also observed some variability in
ADT treatments prescribed versus actual ADT treatments administered; the Center-
ID, however, had a negligible role to play in such alterations and instead PSA and
total Gleason score had significant roles to play in such decisions. We also noticed
that the performance status measure had a negative effect on model predictability
and hence we dropped it from our feature set. We feel that performance status will
be a critical feature in treatment outcome predictions in the future, currently which
is outside the scope of this work. Additionally, Risk showed up as the primary feature
in predicting ST vs. LT ADT duration. We also observed that the primary reason for
treatment plans to be non-concordant with NCCN is due to the ADT course duration
not following the guidelines.
To better understand the impact of non-clinical features like Center-ID in predict-
ing whether the treatment plans were concordant with NCCN guidelines or not, we
computed the Pearson correlation between center-specific details (such as staffing de-
tails) and the number of non-concordant patients undergoing EBRT-ADT or EBRT-
only treatments (either prescribed or administered). Figure 39 shows a small negative
correlation between staff details and non-concordance; specifically fewer number of
radiation oncologists or radiation therapists led to higher number of non-concordant
patients in all cases; while the number of radiation physicists or other staff mem-
bers did not show any worthwhile correlation. This can be potentially attributed to
higher workloads and scheduling conflicts for radiation oncologists/therapists leading
to non-adherence to ADT treatment duration requirements from NCCN.
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Figure 39 also shows the impact of Center-ID in predicting whether a patient
will undergo EBRT-only or EBRT-ADT treatment. We can observe a strong posi-
tive correlation between EBRT-only treatment selection and the number of radiation
therapists and a less pronounced positive correlation between EBRT-ADT treatment
selection and the number of radiation oncologists. While this positive correlation was
expected as more radiation oncologists or therapists will lead to more patients being
treated with EBRT-ADT or EBRT-only respectively, it is however not clear why the
number of radiation physicists or other staff members correlates poorly with these
treatment types. It can arise from the bias of the selected patient cohort.
Our findings corroborate previous studies showing the impact of non-clinical fac-
tors on prostate cancer treatment patterns. For example, a recent study done on
SEERs data reported that prostate cancer treatment patterns were not strictly in-
fluenced by outcomes data and varied significantly by patient age, insurance status,
financial model, regional bias and socioeconomic factors [98]. An earlier survey on
factors influencing treatment selection for localized prostate cancer suggests that rec-
ognizing the beliefs that patients hold about their cancer and its treatment could
guide the counseling of patients about the treatments available to them and ulti-
mately, help patients make more informed decisions about both their treatments and
subsequent adjustments [99]. Prior work on NCCN non-concordance was conducted
on elderly patients with high-risk prostate cancer from SEERs was reported that
NCCN concordance in elderly patients with aggressive prostate cancer is low [100].
These findings underline the importance of non-clinical factors in treatment deci-
sions, however, reported results were based on single center data; hence they could
not identify the center-specific bias. However, such non-clinical factors can vary ap-
preciably between multiple centers and result in the bias; our future work will include
such non-clinical features from the VHA centers to identify the proper reasons behind
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such center-specific bias.
Fig 39: Pearson correlation between center details (Number of radiation oncolo-
gists, radiation physicists, radiation therapists and Other staff), and (i) treatment
non-concordance (number of non-concordant patients considering all treatments pre-
scribed, all treatments administered, EBRT-ADT prescribed, and EBRT-ADT ad-
ministered), and (ii) treatment selections (number of patients treated with EBRT-
only or with EBRT-ADT).
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Limitations
This work has following limitations. First, in data collected for this work includes
patients treated with EBRT only or EBRT with ADT. There are other modalities
such as Brachytherapy and Surgery. Patients treated with all modalities will provide a
better understanding treatment selection practices. Second, we have analyzed overall
treatment selected not the sequence of treatment given in multi-modality treatments.
Third, maximum of only 20 patients were considered from each of 34 RT treatment
centers, which is small number of patients as representative for analysis of treatment
selection practices.
6.5 Conclusion
The VHA ROPA dataset was extracted from recently treated patients having
very little to no follow-up data for oncological outcome analysis. Similar predictive
models will be built in the future for treatment outcome analysis considering a patient
cohort that was treated at earlier dates. Additionally, the ADT duration is generally
dependent on the type of drugs used. In this study, we calculated ADT administered
duration based on the ADT injection dates; the calculated ADT duration may slightly
change considering the ADT injection types. Finally, our study depicts the impor-
tance of non-clinical factors, such as Center-ID, in predictive models for treatment
selection or concordance to NCCN guidelines. In the future, we will investigate the
effects of other types of non-clinical factors (not limited to staffing) pertinent to the
specific VHA centers considered here.
Contribution summary: In this chapter, we considered the treatment quality
component of the radiation therapy process and our specific contributions are as
below.
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1. We present feature engineering methods to analyze the treatment selection prac-
tices for High or Intermediate risk prostate cancer patients across 34 different
VHA radiation therapy centers.
2. We demonstrate that there is an inherent bias in the treatment selection process
at the VHA treatment centers. The selected treatments deviate from the NCCN
guidelines and there is little to no correlation for this deviation with specific
treatment center attributes such as, number of radiation oncologists, radiation
therapists, other staff or treatment resources.
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CHAPTER 7
CONCLUSIONS AND FUTURE WORK
7.1 Conclusions
In this dissertation, we have investigated different data science approaches for
standardization, safety, and quality assurance in radiation oncology.
For data standardization, in Chapters 3 and 4, we have presented a novel multi-
view machine learning approach to standardize the radiotherapy structure names. We
considered two views of RT structure data individually, namely, the physician-given
structure names and the imaging based geometric features. For the text classification
problem, we observed that considering only the fastText algorithm works best when
compared to other feature weighting and classification algorithms. Our method was
evaluated with the data from 40 VA radiotherapy centers and tested on an external
dataset from VCU. We demonstrated that our text classification method works well
on multiple disease sites and is also generalizable. To the best of our knowledge,
this is the first and the only model using the physician-given name to predict the
TG-263 standard name using NLP and ML based methods. We also observed that
our approach fails in certain conditions, when enough information is not available
for the model to infer the correct label. This text-classification approach was next
augmented with imaging information, such as geometric information of structures
to build a multi-view pipeline for structure name standardization which improved
the overall accuracy of our methods. We believe that the proposed structure names
standardization methods can help with big data analytics in the radiation therapy
domain using population-derived datasets, including standardization of the treatment
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planning process, clinical decision support systems, treatment quality improvement
programs, and hypothesis-driven clinical research.
For patient safety, in Chapter 5, we analyzed the incident reports from the ra-
diation oncology domain that provide beneficial information to analysts and subject
matter experts to decide on the right course of action. The current trends in digitiza-
tion health care (such as incident reports) and automation of operations and logistics
(such as our proposed automated incident triage and prioritization module), machine
learning methods have become necessary. In this chapter, we compared the tradi-
tional machine learning and transfer learning approaches to automatically identify
the severity of the RT incident based on the incident description. We demonstrated
that this transfer learning using the ULMFiT algorithm outperforms a standard su-
pervised machine learning-based approach. With the limited data, our approach pro-
vided encouraging results towards the end goal of a fully automated incident triage
and prioritization system in the future. Additional data from the national safety
registry RO-ILS should help improve our proposed model’s performance. Our mod-
els can also work on retrospective data on incident reports to automatically classify
the incident severity and provide rapid summarization of past events for subsequent
data-driven research studies. There are no specific guidelines on incident reporting
practices, specifically the structure of the incident description. Hence, the length of
the incident descriptions varied depending on the severity types and across institu-
tions (VCU and VHA). Thus, we believe there is a need and opportunity to build
guidelines on incident reporting practices.
For quality assurance, in Chapter 6, we presented a machine learning pipeline to
assess the treatment quality for prostate cancer patients considering clinical datasets
from both VHA and VCU. The goal of this work was to build a predictive model for
assessing whether radiation therapy treatment plans adhere to the NCCN guidelines
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or not. We additionally observed that non-adherence to NCCN standards did not
exhibit any correlation with the radiation therapy center-specific features, such as
the number of radiation oncologists, therapists, physicists, and other staff. However,
the treatment plan prediction models exhibited a center-specific bias demonstrating
that individual RT-centers exercise their own preference in choosing the treatment
plans. However, the identification of exact features that affect these preferences is
part of our future work.
7.2 Future Work
In Chapter 3, we presented the structure name standardization pipeline while in
Chapter 4, we presented different methods to integrate the heterogeneous radiother-
apy structure data for structure name standardization. We next outline the following
future works for the structure name standardization problem.
• In the Late integration approach, we have used the top 100 SVD features with
an RF classification algorithm. However, there are more suitable algorithms for
image data such as 2D CNN algorithm, ResNet [101], and VoxNet and a 3D
CNN supervised classification algorithm [102]. The radiotherapy structure set
is 3D in nature, making it more suitable to solve using 3D algorithms.
• Our structure name standardization ML pipeline, from data preprocessing to
prediction, works as a standalone system. We plan to create a seamless enter-
prise informatics platform that automatically collects data from the treatment
planning systems and performs automatic structure name standardization on
retrospective data and stores the standardized names back in databases.
• The current list of OARs identified for both lung and prostate datasets is per
the VA-ROQS project requirement, which has selected these OARs in consensus
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with a team expert. Radiation oncologists also delineate other types of OARs
for each patient, such as Kidney (left and right) and Liver, in prostate cancer
patients. Although these are not critical OARs in prostate cancer treatment, we
believe building a system to identify and standardize all structures delineated
according to the TG-263 guideline provides the radiation therapy healthcare
institutes with an opportunity to produce a robust dataset for downstream
analysis projects.
• Other future works using the standardized structure sets include dose outlier
detection, toxicity prediction, treatment outcome analysis, treatment planning,
automated structure delineations.
In Chapter 5, we presented an approach to automatically identify the severity
of the radiotherapy incident reports based on the textual description provided in the
radiotherapy incident reporting and analysis system (RIRAS). For Chapter 5, we
outline the following future work.
• We have used ULMFiT in our current work for the transfer learning method.
Ther are other contextual word embedding algorithms, ELMo [103], OpenAI
GPT [104], and BERT [105]. In the biomedical domain, researchers have fine-
tuned BERT LM models (SciBERT, clinicalBERT [106], and BioBERT [107])
and reported better performance on downstream tasks over the standard BERT
model. We can integrate similar approaches into the transfer learning model.
Although there are pre-trained biomedical domain-specific BERT based lan-
guage models, which are closely related to radiation oncology, we still believe
that training a radiation oncology-specific BERT model is needed. The na-
tional registry of the radiation oncology incident - learning system (RO-ILS)
collects the incidents and analysis reports submitted from radiation oncology
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institutes across the USA. We believe that fine-tuning the SciBERT, bioBERT,
clinicalBERT, and BERT-base separately, and comparing the performance of
downstream tasks provide the understanding of the model’s dependency on do-
main knowledge.
• Incident analysis involves many other steps along with the severity assessment,
such as identifying the incident process step and providing the short and ap-
propriate title to the analyzed report. The title of the analysis report needs to
represent the issue reported. We believe that a fine-tuned BERT model will give
better results for this task. Another vital work will be to identify similar reports
in the incident database and recommend the solution based on the previously
analyzed reports.
• Understanding why incidents occur may be more critical for effecting change
than understanding what events have occurred. Further studies exploring NLP’s
ability to classify incident reports by contributory factors could offer more learn-
ing opportunities. We believe contextual topic modeling would be beneficial for
determining the contributory factors.
• In the current RIRAS dataset, one SME assigns severity to the incident reported
based on the incident description. Incident analysis is a highly subjective task;
to reduce the subjectiveness and make it more objective, we believe each report
must be analyzed by two or more SMEs independently. The inter-annotator
agreement score needs to be calculated to understand the subjective biases in
reviewers. Addressing these biases will generate more consistent incident anal-
ysis reports and offer more appropriate severity labels for automated severity
assignment models.
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Finally, we discuss the future work for Chapter 6.
• We explored the multi-center treatment selection practices. In current work,
we have analyzed the treatment selection practices. However, the treatments
selected were multi-modality treatments. A plausible future work is to analyze
the treatment selection paths and their association with patient pre-treatment




AAPM Association of Physicists in Medicine
AJCC American Joint Committee on Cancer API Application Programing Interface
ASTRO American Society for Radiation Oncology
DICOM Digital Imaging and Communications in Medicine
ESTRO European Society for Therapeutic Radiation Oncology
EHR Electronic Health Record
HIPAA Health Insurance Portability and Accountability Act
JSON JavaScript Object Notation
NCCN National Comprehensive Cancer Network
PACS Picture Archive and Communication Systems
RIRAS Radiotherapy Incident Reporting and Analysis System
RCT Randomized Controlled Trial
RO-ILS Radiation Oncology Incident Learning System
RT Radiation Therapy
TPS Treatment Planning System
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Appendix B
STRUCTURE NAME STANDARDIZATION WITH
PHYSICIAN-GIVEN NAMES
Fig 40: Radiotherapy Structure name distribution per center for Prostate cancer




Fig 41: Radiotherapy Structure names distribution per center for Lung cancer pa-
tients in the VA-ROQS dataset.
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FIGURE Page
Fig 42: VA-ROQS Prostate 10 fold cross-validation results
Fig 43: VA-ROQS Lung 10 fold cross-validation results.
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Structure Name Precision Recall F1-Score Support
Bladder 0.99 0.97 0.98 152
External 1.0 1.0 1.0 119
Femur L 0.99 1.0 1.0 141
Femur R 1.0 0.99 0.99 145
LargeBowel 0.9 0.87 0.88 70
Non OAR 0.99 0.99 0.99 1970
PenileBulb 0.99 1.0 1.0 117
Rectum 0.99 0.99 0.99 148
SeminalVesicles 1.0 0.99 1.0 103
SmallBowel 0.82 0.85 0.84 48
accuracy 0.99 0.99 0.99 3013
macro avg 0.97 0.97 0.97 3013
weighted avg 0.99 0.99 0.99 3013
Table 28: VA-ROQS Prostate 70:30 validation results.
Structure Name Precision Recall F1-Score Support
Bladder 0.96 0.99 0.98 738
External 1.0 1.0 1.0 597
Femur L 0.95 0.98 0.97 711
Femur R 0.95 0.95 0.95 717
LargeBowel 0.86 0.89 0.87 341
Non OAR 0.98 0.98 0.98 9869
PenileBulb 1.0 1.0 1.0 590
Rectum 0.97 0.99 0.98 742
SeminalVesicles 1.0 1.0 1.0 510
SmallBowel 0.77 0.64 0.7 250
accuracy 0.97 0.97 0.97 15065
macro avg 0.94 0.94 0.94 15065
weighted avg 0.97 0.97 0.97 15065
Table 29: VA-ROQS Prostate Center validation results.
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Structure Name Precision Recall F1-Score Support
Bladder 0.99 0.99 0.99 738
External 1.0 1.0 1.0 597
Femur L 0.97 1.0 0.99 711
Femur R 0.98 0.99 0.98 717
LargeBowel 0.87 0.93 0.9 341
Non OAR 0.99 0.99 0.99 9869
PenileBulb 1.0 1.0 1.0 590
Rectum 0.99 0.99 0.99 742
SeminalVesicles 1.0 1.0 1.0 510
SmallBowel 0.85 0.73 0.79 250
accuracy 0.98 0.98 0.98 15065
macro avg 0.96 0.96 0.96 15065
weighted avg 0.98 0.98 0.98 15065
Table 30: VA-ROQS Prostate dataset 5 fold validation results.
Structure Name Precision Recall F1-Score Support
Bladder 0.99 0.99 0.99 738
External 1.0 1.0 1.0 597
Femur L 0.97 1.0 0.99 711
Femur R 0.98 0.99 0.98 717
LargeBowel 0.87 0.93 0.9 341
Non OAR 0.99 0.99 0.99 9869
PenileBulb 1.0 1.0 1.0 590
Rectum 0.99 0.99 0.99 742
SeminalVesicles 1.0 1.0 1.0 510
SmallBowel 0.81 0.76 0.79 250
accuracy 0.98 0.98 0.98 15065
macro avg 0.96 0.97 0.96 15065
weighted avg 0.98 0.98 0.98 15065
Table 31: VA-ROQS Prostate dataset 10 fold validation results.
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Structure Name Precision Recall F1-Score Support
BrachialPlexus 1.0 1.0 1.0 9
BrachialPlexus L 1.0 1.0 1.0 12
BrachialPlexus R 1.0 1.0 1.0 14
Carina 1.0 1.0 1.0 99
Esophagus 1.0 0.99 1.0 128
Heart 1.0 0.99 0.99 141
Lung L 0.99 1.0 1.0 110
Lung R 1.0 0.99 1.0 113
Lungs 1.0 0.96 0.98 92
Non OAR 0.99 1.0 1.0 1750
SpinalCord 0.99 0.97 0.98 141
accuracy 1.0 1.0 1.0 2609
macro avg 1.0 0.99 0.99 2609
weighted avg 1.0 1.0 0.99 2609
Table 32: VA-ROQS Lung dataset 70:30 validation results.
Structure Name Precision Recall F1-Score Support
BrachialPlexus 0.57 0.86 0.68 44
BrachialPlexus L 0.97 0.56 0.71 59
BrachialPlexus R 0.9 0.94 0.92 69
Carina 1.0 1.0 1.0 497
Esophagus 0.98 0.99 0.99 636
Heart 0.98 0.99 0.99 693
Lung L 0.99 0.97 0.98 555
Lung R 0.98 0.98 0.98 563
Lungs 0.97 0.98 0.97 439
Non OAR 0.99 0.99 0.99 8800
SpinalCord 0.96 0.97 0.96 689
accuracy 0.99 0.99 0.99 13044
macro avg 0.94 0.93 0.93 13044
weighted avg 0.99 0.99 0.99 13044
Table 33: VA-ROQS Lung dataset Center validation results.
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Structure Name Precision Recall F1-Score Support
BrachialPlexus 0.98 0.91 0.94 44
BrachialPlexus L 0.92 0.98 0.95 59
BrachialPlexus R 0.99 0.99 0.99 69
Carina 1.0 1.0 1.0 497
Esophagus 0.99 1.0 0.99 636
Heart 0.99 1.0 1.0 693
Lung L 0.99 0.99 0.99 555
Lung R 0.99 1.0 1.0 563
Lungs 0.98 0.99 0.99 439
Non OAR 1.0 0.99 1.0 8800
SpinalCord 0.97 0.98 0.98 689
accuracy 0.99 0.99 0.99 13044
macro avg 0.98 0.98 0.98 13044
weighted avg 0.99 0.99 0.99 13044
Table 34: VA-ROQS Lung dataset 5 fold validation results.
Structure Name Precision Recall F1-Score Support
BrachialPlexus 0.98 1.0 0.99 44
BrachialPlexus L 0.98 0.98 0.98 59
BrachialPlexus R 0.99 0.99 0.99 69
Carina 1.0 1.0 1.0 497
Esophagus 0.99 0.99 0.99 636
Heart 0.99 1.0 0.99 693
Lung L 0.99 0.99 0.99 555
Lung R 1.0 1.0 1.0 563
Lungs 0.98 0.99 0.99 439
Non OAR 1.0 0.99 1.0 8800
SpinalCord 0.97 0.98 0.98 689
accuracy 0.99 0.99 0.99 13044
macro avg 0.99 0.99 0.99 13044
weighted avg 0.99 0.99 0.99 13044
Table 35: VA-ROQS Lung dataset 10 fold Validation results.
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